Fbxo2 (also known as Fbs1, Fbx2, NFB42) is the substrate-recognition component of the SCF(Fbxo2) E3 ubiquitin-protein ligase complex (SKP1-CUL1-FBXO2-RBX1). It functions primarily in the endoplasmic reticulum-associated degradation (ERAD) pathway, where it recognizes and binds N-linked high-mannose oligosaccharides on misfolded glycoproteins that have been retrotranslocated from the ER to the cytosol. The sugar-binding domain (FBA domain) recognizes Man3GlcNAc2 (the innermost chitobiose core of N-glycans), and binding is enhanced when glycoproteins are denatured because denaturation exposes the normally buried chitobiose structure (PMID:15723043, PMID:14990996). Fbxo2 is NOT a chaperone; it is a glycoprotein sensor that targets substrates for ubiquitination and proteasomal degradation. It also prevents cytosolic aggregation of retrotranslocated glycoproteins (PMID:17215248). In neurons, Fbxo2 mediates activity-dependent degradation of NMDA receptor NR1 subunits at glutamatergic synapses (PMID:15809437). Expression is enriched in brain and cochlea; Fbxo2 knockout mice develop progressive hearing loss due to cochlear cell degeneration (PMID:17494702). Fbxo2 also associates with p97/VCP AAA ATPase for substrate extraction from the ER membrane (PMID:15723043).
Definition: Recognition of N-glycans on misfolded glycoproteins to target them for ubiquitin-dependent degradation. Distinct from chaperone activity (no protein refolding) and from general misfolded protein binding (recognition is glycan-mediated rather than via exposed hydrophobic patches). Examples include Fbxo2 (Fbs1) and Fbxo6 (Fbs2) in the ERAD pathway.
Justification: No existing GO term precisely captures the mechanism of Fbxo2. "Denatured protein binding" (GO:0031249, being obsoleted) is inaccurate because Fbxo2 binds glycans not the protein moiety. "Misfolded protein binding" (GO:0051787) implies direct recognition of misfolded protein conformation. "Carbohydrate binding" is correct but does not capture the quality-control context. A term for glycan-based misfolded glycoprotein recognition would fill this gap. See also the UNFOLDED_PROTEIN_BINDING project discussion of "misfolded protein sensor activity."
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0036503
ERAD pathway
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for involvement in the ERAD pathway. This is a core function of Fbxo2, well-established by multiple experimental papers. Fbxo2 recognizes N-glycans on misfolded glycoproteins retrotranslocated from the ER and promotes their ubiquitination and proteasomal degradation (PMID:12140560, PMID:15723043).
Reason: ERAD is the central biological pathway in which Fbxo2 operates. The IBA annotation is consistent with direct experimental evidence from PMID:12140560 and PMID:15723043. The phylogenetic inference is well-supported.
Supporting Evidence:
PMID:12140560
expression of the mutant Fbx2 Delta F, which lacks the F-box domain that is essential for forming the SCF complex, appreciably blocks degradation of typical substrates of the ER-associated degradation pathway
PMID:15723043
the SCF(Fbs1,2) ubiquitin-ligase complexes that contribute to ubiquitination of glycoproteins are involved in the ER-associated degradation pathway
|
|
GO:0005737
cytoplasm
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for cytoplasm localization. Fbxo2 operates in the cytosol, where it recognizes retrotranslocated glycoproteins from the ER. More specifically it localizes to the cytosol and to microsome membrane peripheral cytoplasmic side (UniProt).
Reason: Cytoplasm is a correct general localization. The IBA is consistent with IDA evidence for cytosol (PMID:12140560). The broader term cytoplasm is acceptable for an IBA.
Supporting Evidence:
PMID:12140560
Pre-integrin beta 1 is a target of Fbx2; these two proteins interact in the cytosol after inhibition of the proteasome
|
|
GO:0006516
glycoprotein catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for involvement in glycoprotein catabolic process. This is a core function. Fbxo2 promotes ubiquitination and subsequent proteasomal degradation of N-glycosylated proteins (PMID:12140560, PMID:15723043).
Reason: Glycoprotein catabolism is the downstream consequence of Fbxo2-mediated substrate recognition and ubiquitination. Well-supported by direct experimental evidence.
Supporting Evidence:
PMID:12140560
SCF(Fbx2) ubiquitinates N-glycosylated proteins that are translocated from the ER to the cytosol by the quality control mechanism
|
|
GO:0019005
SCF ubiquitin ligase complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for membership in the SCF ubiquitin ligase complex. Fbxo2 is the F-box substrate recognition subunit of the SCF(Fbxo2) complex consisting of CUL1, RBX1, SKP1, and FBXO2 (PMID:12140560, PMID:17389369).
Reason: SCF complex membership is a core structural aspect of Fbxo2 function, extensively validated by crystal structures (PMID:17389369) and biochemical data (PMID:12140560).
Supporting Evidence:
PMID:12140560
N-glycan serves as a signal for degradation by the Skp1-Cullin1-Fbx2-Roc1 (SCF(Fbx2)) ubiquitin ligase complex
|
|
GO:0031146
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for involvement in SCF-dependent proteasomal ubiquitin-dependent protein catabolic process. This describes the pathway Fbxo2 participates in.
Reason: This is the specific proteasomal degradation pathway that SCF(Fbxo2) mediates. Well-supported by PMID:12140560 demonstrating that SCF(Fbxo2) ubiquitinates glycoproteins for proteasomal degradation.
Supporting Evidence:
PMID:12140560
The F-box protein Fbx2 (ref. 4) binds specifically to proteins attached to N-linked high-mannose oligosaccharides and subsequently contributes to ubiquitination of N-glycosylated proteins
|
|
GO:0061630
ubiquitin protein ligase activity
|
IBA
GO_REF:0000033 |
MODIFY |
Summary: IBA annotation for ubiquitin protein ligase activity with qualifier "contributes_to". Fbxo2 is the substrate recognition component of the SCF(Fbxo2) E3 ligase complex; it does not itself possess catalytic E3 ligase activity but contributes to the complex's activity by conferring substrate specificity (PMID:12140560, PMID:17389369).
Reason: While "contributes_to" ubiquitin protein ligase activity is technically defensible as Fbxo2 is a subunit of an active E3 ligase complex, the more precise molecular function of Fbxo2 is as a ubiquitin ligase substrate adaptor. GO:1990756 "ubiquitin-like ligase-substrate adaptor activity" better captures Fbxo2's actual role: bringing together the E3 ligase and its substrate through glycan recognition.
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:17389369
In SCF ubiquitin ligases, a diverse array of F-box proteins confers substrate specificity. Fbs1/Fbx2, a member of the F-box protein family, recognizes high-mannose oligosaccharides
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for cytoplasm localization. Redundant with IBA and IDA evidence for cytoplasm/cytosol localization.
Reason: Correct and consistent with experimental evidence. IEA is broader than the IDA cytosol annotation but not incorrect.
|
|
GO:0006516
glycoprotein catabolic process
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation for glycoprotein catabolic process, inferred by ARBA machine learning. Redundant with IBA and IDA evidence for the same term.
Reason: Correct and consistent with experimental data from PMID:12140560 and PMID:15723043.
|
|
GO:0019005
SCF ubiquitin ligase complex
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation for SCF ubiquitin ligase complex membership. Redundant with IBA and IDA evidence.
Reason: Correct. Fbxo2 is a well-characterized component of the SCF(Fbxo2) complex.
|
|
GO:0030246
carbohydrate binding
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: IEA annotation for carbohydrate binding, inferred from UniProt keyword "Lectin". Carbohydrate binding is a core molecular function of Fbxo2. The FBA (F-box associated) domain specifically binds high-mannose N-glycans (PMID:14990996, PMID:17389369).
Reason: Correct and a core function. Carbohydrate binding is well-established experimentally. While a more specific term like oligosaccharide binding (GO:0070492) might be more precise, carbohydrate binding is not incorrect for an IEA annotation.
|
|
GO:0031146
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation for SCF-dependent proteasomal degradation. Redundant with IBA and IDA evidence for the same term.
Reason: Correct and consistent with experimental evidence from PMID:12140560.
|
|
GO:0036503
ERAD pathway
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: IEA annotation for ERAD pathway involvement. Redundant with IBA and IDA evidence.
Reason: Correct. ERAD is the core biological pathway of Fbxo2 function.
|
|
GO:0005515
protein binding
|
IPI
PMID:17389369 Structural basis for the selection of glycosylated substrate... |
MODIFY |
Summary: IPI annotation for protein binding based on crystal structure of SCF(Fbs1) with glycoprotein substrate RNase1 (PMID:17389369). The interaction partner is UniProtKB:P61823 (bovine RNase1). The crystal structure revealed the structural basis for how the sugar-binding domain selects glycosylated substrates.
Reason: "Protein binding" is uninformative. The interaction demonstrated in PMID:17389369 is actually glycan-mediated binding of a glycoprotein substrate. The correct MF annotation is carbohydrate binding or more specifically oligosaccharide binding, or the substrate adaptor activity. Since these are already captured by other annotations, this particular "protein binding" annotation should be modified to the more informative substrate adaptor term.
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:17389369
The structure of the SBD-glycoprotein complex indicates that the SBD primarily recognizes Man(3)GlcNAc(2), thereby explaining the broad activity of the enzyme against various glycoproteins
|
|
GO:0005515
protein binding
|
IPI
PMID:17389369 Structural basis for the selection of glycosylated substrate... |
MODIFY |
Summary: Second IPI annotation for protein binding from PMID:17389369, this time with UniProtKB:P63208-1 (Skp1). The crystal structure showed the Skp1-Fbs1 complex architecture with the F-box domain mediating Skp1 interaction.
Reason: "Protein binding" is uninformative. The interaction with Skp1 is an obligate structural interaction within the SCF complex. This is better captured by the existing SCF complex membership annotation (GO:0019005) and the substrate adaptor activity (GO:1990756).
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:17389369
we determined the crystal structures of the Skp1-Fbs1 complex and the sugar-binding domain (SBD) of the Fbs1-glycoprotein complex
|
|
GO:0005515
protein binding
|
IPI
PMID:15809437 Activity-dependent NMDA receptor degradation mediated by ret... |
MODIFY |
Summary: IPI annotation for protein binding based on PMID:15809437, with interaction partner PR:P35438 (NR1/GRIN1 NMDA receptor subunit). Fbxo2 binds to high-mannose glycans of the NR1 ectodomain and promotes NR1 ubiquitination.
Reason: "Protein binding" is uninformative. The binding to NR1 is glycan-mediated (Fbxo2 binds the high-mannose glycans on the NR1 ectodomain) and represents substrate recognition for ubiquitination. This is better captured by carbohydrate binding (GO:0030246) and/or ubiquitin-like ligase-substrate adaptor activity (GO:1990756).
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:15809437
the F-box protein, Fbx2, bound to high-mannose glycans of the NR1 ectodomain. F-box proteins specify ubiquitination by linking protein substrates to the terminal E3 ligase
|
|
GO:0005515
protein binding
|
IPI
PMID:15723043 Glycoprotein-specific ubiquitin ligases recognize N-glycans ... |
MODIFY |
Summary: IPI annotation for protein binding from PMID:15723043, with interaction partner PR:P09055 (integrin beta-1). Fbxo2 interacts with integrin-beta1 (an ERAD substrate) in the cytosol in a manner dependent on p97 ATPase activity.
Reason: "Protein binding" is uninformative. The interaction with integrin-beta1 represents glycan-mediated substrate recognition. This is better captured by the substrate adaptor activity term and the ERAD pathway annotation.
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:15723043
The SCF(Fbs1) complex was associated with p97/VCP AAA ATPase and bound to integrin-beta1, one of the SCF(Fbs1) substrates, in the cytosol in a manner dependent on p97 ATPase activity
|
|
GO:0005515
protein binding
|
IPI
PMID:15723043 Glycoprotein-specific ubiquitin ligases recognize N-glycans ... |
MODIFY |
Summary: Second IPI annotation for protein binding from PMID:15723043 (with PR:Q01853, VCP/p97). This is a separate entry from the same reference, representing the VCP/p97 interaction partner.
Reason: Same reasoning as the other PMID:15723043 protein binding annotation. The VCP/p97 interaction is part of the ERAD machinery. "Protein binding" is uninformative; the ERAD pathway annotation already captures this functional context.
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:15723043
The SCF(Fbs1) complex was associated with p97/VCP AAA ATPase
|
|
GO:0005737
cytoplasm
|
ISO
GO_REF:0000119 |
ACCEPT |
Summary: ISO annotation for cytoplasm localization, transferred from human ortholog UniProtKB:Q9UK22 (FBXO2). Redundant with IBA and IDA evidence.
Reason: Correct and consistent with experimental evidence for cytoplasm/cytosol localization.
|
|
GO:0008285
negative regulation of cell population proliferation
|
ISO
GO_REF:0000096 |
KEEP AS NON CORE |
Summary: ISO annotation for negative regulation of cell population proliferation, transferred from rat ortholog RGD:621751. This is not a well-characterized function of Fbxo2. The core function of Fbxo2 is ERAD-linked glycoprotein degradation, not cell proliferation regulation.
Reason: While Fbxo2-mediated degradation of glycoprotein substrates could indirectly affect cell proliferation, this is not a core evolved function. The annotation is based on ortholog transfer from rat and may reflect a secondary/downstream consequence of Fbxo2's ubiquitin ligase activity rather than a specific proliferation-regulatory role. Keeping as non-core since the evidence is indirect.
|
|
GO:0098890
extrinsic component of postsynaptic membrane
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: ISO annotation for extrinsic component of postsynaptic membrane, transferred from rat ortholog. This is consistent with Fbxo2's role in degrading NMDA receptor NR1 subunits at the postsynapse (PMID:15809437).
Reason: This localization is consistent with the experimentally demonstrated role of Fbxo2 at glutamatergic synapses (PMID:15809437). Fbxo2 acts on NR1 subunits at the postsynaptic membrane, and being a cytoplasmic peripheral protein would make it an extrinsic component of the postsynaptic membrane.
Supporting Evidence:
PMID:15809437
the F-box protein, Fbx2, bound to high-mannose glycans of the NR1 ectodomain
|
|
GO:0098978
glutamatergic synapse
|
ISO
GO_REF:0000096 |
ACCEPT |
Summary: ISO annotation for glutamatergic synapse localization, transferred from rat ortholog. Redundant with IDA evidence from SynGO (PMID:15809437).
Reason: Correct. Fbxo2 localizes to glutamatergic synapses where it mediates NMDA receptor degradation. Consistent with direct experimental evidence from PMID:15809437.
|
|
GO:0098978
glutamatergic synapse
|
IDA
PMID:15809437 Activity-dependent NMDA receptor degradation mediated by ret... |
ACCEPT |
Summary: IDA annotation from SynGO for glutamatergic synapse localization based on PMID:15809437. Kato et al. showed Fbxo2 localizes to hippocampal neurons and specifically targets NR1 at glutamatergic synapses. Multiple evidence lines (ECO:0000314, ECO:0005589, ECO:0007695, ECO:0007719) all support this.
Reason: Well-supported by PMID:15809437 which demonstrated Fbxo2 localization and function at glutamatergic synapses in hippocampal neurons.
Supporting Evidence:
PMID:15809437
When expressed in hippocampal neurons, this Fbx2 dominant-negative mutant augmented NR1 subunit levels and NMDA receptor-mediated currents in an activity-dependent fashion
|
|
GO:0098978
glutamatergic synapse
|
IMP
PMID:15809437 Activity-dependent NMDA receptor degradation mediated by ret... |
ACCEPT |
Summary: IMP annotation from SynGO for glutamatergic synapse localization based on mutant phenotype analysis (dominant-negative Fbxo2) in PMID:15809437.
Reason: The dominant-negative Fbxo2 mutant increased NR1 levels and NMDA receptor currents at glutamatergic synapses, demonstrating that endogenous Fbxo2 functions at these synapses (PMID:15809437).
Supporting Evidence:
PMID:15809437
this Fbx2 dominant-negative mutant augmented NR1 subunit levels and NMDA receptor-mediated currents in an activity-dependent fashion
|
|
GO:0099576
regulation of protein catabolic process at postsynapse, modulating synaptic transmission
|
IDA
PMID:15809437 Activity-dependent NMDA receptor degradation mediated by ret... |
ACCEPT |
Summary: IDA annotation from SynGO for regulation of postsynaptic protein catabolism. Fbxo2 promotes ubiquitination and degradation of NMDA receptor NR1 subunits at the postsynapse, thereby modulating synaptic transmission (PMID:15809437).
Reason: This is a well-supported neuronal-specific function of Fbxo2. Kato et al. showed that Fbxo2 mediates activity-dependent NR1 degradation at postsynaptic sites, directly modulating NMDA receptor-mediated currents.
Supporting Evidence:
PMID:15809437
ubiquitination of NR1 was increased by Fbx2 and diminished by an Fbx2 dominant-negative mutant
|
|
GO:0099576
regulation of protein catabolic process at postsynapse, modulating synaptic transmission
|
IMP
PMID:15809437 Activity-dependent NMDA receptor degradation mediated by ret... |
ACCEPT |
Summary: IMP annotation from SynGO for postsynaptic protein catabolism regulation, based on mutant phenotype evidence. The dominant-negative Fbxo2 augmented NR1 levels and NMDA receptor currents.
Reason: Well-supported by the dominant-negative experiment in PMID:15809437 showing that blocking Fbxo2 function increased NR1 levels and NMDA receptor currents.
Supporting Evidence:
PMID:15809437
this Fbx2 dominant-negative mutant augmented NR1 subunit levels and NMDA receptor-mediated currents in an activity-dependent fashion
|
|
GO:0016567
protein ubiquitination
|
IEA
GO_REF:0000041 |
ACCEPT |
Summary: IEA annotation for protein ubiquitination, based on UniPathway vocabulary mapping. Fbxo2 participates in protein ubiquitination as part of the SCF(Fbxo2) complex.
Reason: Correct. Fbxo2 is integral to the SCF(Fbxo2) E3 ubiquitin ligase complex that ubiquitinates glycoprotein substrates. Consistent with IDA evidence from PMID:12140560.
|
|
GO:0005515
protein binding
|
IPI
PMID:15809437 Activity-dependent NMDA receptor degradation mediated by ret... |
MODIFY |
Summary: IPI annotation for protein binding from PMID:15809437, with interaction partner PR:P35438 (NR1/GRIN1). This is the MGI-curated version of the NR1 interaction. Redundant with the SynGO-curated IPI annotation from the same paper.
Reason: "Protein binding" is uninformative. The NR1 interaction is glycan-mediated and represents substrate recognition for ubiquitination. Better captured by GO:1990756 ubiquitin-like ligase-substrate adaptor activity.
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:15809437
the F-box protein, Fbx2, bound to high-mannose glycans of the NR1 ectodomain
|
|
GO:0005829
cytosol
|
IDA
PMID:12140560 E3 ubiquitin ligase that recognizes sugar chains. |
ACCEPT |
Summary: IDA annotation for cytosol localization from the landmark paper identifying SCF(Fbxo2) (PMID:12140560). Fbxo2 interacts with its glycoprotein substrate pre-integrin beta-1 in the cytosol after proteasome inhibition.
Reason: Well-supported. Yoshida et al. demonstrated cytosolic localization of Fbxo2 and its interaction with substrates in the cytosol (PMID:12140560). UniProt also lists cytoplasm and microsome membrane (cytoplasmic side) as subcellular locations.
Supporting Evidence:
PMID:12140560
Pre-integrin beta 1 is a target of Fbx2; these two proteins interact in the cytosol after inhibition of the proteasome
|
|
GO:0006516
glycoprotein catabolic process
|
IDA
PMID:12140560 E3 ubiquitin ligase that recognizes sugar chains. |
ACCEPT |
Summary: IDA annotation for glycoprotein catabolic process from PMID:12140560. SCF(Fbxo2) ubiquitinates N-glycosylated proteins translocated from the ER, promoting their proteasomal degradation.
Reason: Core function. Directly demonstrated in PMID:12140560 that Fbxo2 targets glycoproteins for degradation.
Supporting Evidence:
PMID:12140560
SCF(Fbx2) ubiquitinates N-glycosylated proteins that are translocated from the ER to the cytosol by the quality control mechanism
|
|
GO:0016567
protein ubiquitination
|
IDA
PMID:12140560 E3 ubiquitin ligase that recognizes sugar chains. |
ACCEPT |
Summary: IDA annotation for protein ubiquitination from PMID:12140560. Fbxo2 contributes to ubiquitination of N-glycosylated proteins as part of the SCF(Fbxo2) complex.
Reason: Core function. Directly demonstrated in PMID:12140560.
Supporting Evidence:
PMID:12140560
The F-box protein Fbx2 (ref. 4) binds specifically to proteins attached to N-linked high-mannose oligosaccharides and subsequently contributes to ubiquitination of N-glycosylated proteins
|
|
GO:0019005
SCF ubiquitin ligase complex
|
IDA
PMID:12140560 E3 ubiquitin ligase that recognizes sugar chains. |
ACCEPT |
Summary: IDA annotation for SCF ubiquitin ligase complex membership from PMID:12140560. Fbxo2 was identified as the F-box protein forming the SCF(Fbxo2) complex (SKP1-CUL1-FBXO2-ROC1).
Reason: Core structural annotation. The SCF(Fbxo2) complex was originally identified in PMID:12140560 and confirmed by crystal structures (PMID:17389369).
Supporting Evidence:
PMID:12140560
N-glycan serves as a signal for degradation by the Skp1-Cullin1-Fbx2-Roc1 (SCF(Fbx2)) ubiquitin ligase complex
|
|
GO:0031146
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
|
IDA
PMID:12140560 E3 ubiquitin ligase that recognizes sugar chains. |
ACCEPT |
Summary: IDA annotation for SCF-dependent proteasomal degradation from PMID:12140560. SCF(Fbxo2) mediates ubiquitin-dependent proteasomal degradation of glycoprotein substrates.
Reason: Core function. The dominant-negative Fbxo2 Delta-F blocked ERAD substrate degradation (PMID:12140560), directly demonstrating SCF-dependent proteasomal degradation.
Supporting Evidence:
PMID:12140560
expression of the mutant Fbx2 Delta F, which lacks the F-box domain that is essential for forming the SCF complex, appreciably blocks degradation of typical substrates of the ER-associated degradation pathway
|
|
GO:0006511
ubiquitin-dependent protein catabolic process
|
IDA
PMID:15723043 Glycoprotein-specific ubiquitin ligases recognize N-glycans ... |
ACCEPT |
Summary: IDA annotation for ubiquitin-dependent protein catabolic process from PMID:15723043. This is a parent term of the more specific SCF-dependent proteasomal degradation annotation. Fbxo2 mediates ubiquitin-dependent degradation of glycoprotein substrates.
Reason: Correct, though redundant with the more specific GO:0031146 annotation. Keeping as the evidence from PMID:15723043 demonstrated ubiquitin-dependent degradation.
Supporting Evidence:
PMID:15723043
the SCF(Fbs1,2) ubiquitin-ligase complexes that contribute to ubiquitination of glycoproteins are involved in the ER-associated degradation pathway
|
|
GO:0031396
regulation of protein ubiquitination
|
IDA
PMID:15809437 Activity-dependent NMDA receptor degradation mediated by ret... |
ACCEPT |
Summary: IDA annotation for regulation of protein ubiquitination from PMID:15809437. Fbxo2 increased NR1 ubiquitination, and the dominant-negative mutant diminished it.
Reason: Well-supported. PMID:15809437 showed that Fbxo2 expression increased NR1 ubiquitination and the dominant-negative form decreased it, demonstrating regulation of ubiquitination at the synapse.
Supporting Evidence:
PMID:15809437
ubiquitination of NR1 was increased by Fbx2 and diminished by an Fbx2 dominant-negative mutant
|
|
GO:0043197
dendritic spine
|
IDA
PMID:15809437 Activity-dependent NMDA receptor degradation mediated by ret... |
ACCEPT |
Summary: IDA annotation for dendritic spine localization from PMID:15809437. Fbxo2 was shown to localize to hippocampal neurons including dendritic spines where it targets NMDA receptors for degradation.
Reason: Consistent with the synaptic function of Fbxo2 in degrading NR1 subunits. Dendritic spines are the postsynaptic compartment of glutamatergic synapses.
Supporting Evidence:
PMID:15809437
When expressed in hippocampal neurons, this Fbx2 dominant-negative mutant augmented NR1 subunit levels and NMDA receptor-mediated currents
|
|
GO:0005515
protein binding
|
IPI
PMID:15723043 Glycoprotein-specific ubiquitin ligases recognize N-glycans ... |
MODIFY |
Summary: IPI annotation for protein binding from PMID:15723043, with interaction partner PR:Q01853 (VCP/p97). This is the MGI-curated record of Fbxo2 interaction with VCP/p97 AAA ATPase.
Reason: "Protein binding" is uninformative. The VCP/p97 interaction is part of the ERAD machinery coordination. Better captured by ERAD pathway annotation.
Proposed replacements:
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:15723043
The SCF(Fbs1) complex was associated with p97/VCP AAA ATPase and bound to integrin-beta1, one of the SCF(Fbs1) substrates, in the cytosol in a manner dependent on p97 ATPase activity
|
|
GO:0005829
cytosol
|
TAS
PMID:15723043 Glycoprotein-specific ubiquitin ligases recognize N-glycans ... |
ACCEPT |
Summary: TAS annotation for cytosol localization from PMID:15723043. Yoshida et al. showed Fbxo2 binds integrin-beta1 in the cytosol dependent on p97 ATPase activity.
Reason: Correct and consistent with IDA evidence from PMID:12140560. Redundant but valid.
Supporting Evidence:
PMID:15723043
The SCF(Fbs1) complex was associated with p97/VCP AAA ATPase and bound to integrin-beta1, one of the SCF(Fbs1) substrates, in the cytosol
|
|
GO:0006516
glycoprotein catabolic process
|
IDA
PMID:15723043 Glycoprotein-specific ubiquitin ligases recognize N-glycans ... |
ACCEPT |
Summary: IDA annotation for glycoprotein catabolic process from PMID:15723043. Redundant with the same annotation from PMID:12140560, but independently supported by this paper which demonstrated Fbs1/Fbs2 interaction with denatured glycoproteins.
Reason: Core function, independently confirmed in PMID:15723043.
Supporting Evidence:
PMID:15723043
the SCF(Fbs1,2) ubiquitin-ligase complexes that contribute to ubiquitination of glycoproteins are involved in the ER-associated degradation pathway
|
|
GO:0031249
denatured protein binding
|
IDA
PMID:15723043 Glycoprotein-specific ubiquitin ligases recognize N-glycans ... |
MODIFY |
Summary: IDA annotation for denatured protein binding. GO:0031249 is being obsoleted. Yoshida et al. (PMID:15723043) showed that Fbs1 and Fbs2 "interacted with denatured glycoproteins...more efficiently than native proteins" and proposed that "Fbs proteins distinguish native from unfolded glycoproteins by sensing the exposed chitobiose structure." Critically, this is NOT general denatured protein binding. Fbxo2 recognizes the N-glycan (chitobiose core) that becomes exposed upon glycoprotein denaturation. It does not bind non-glycosylated denatured proteins and is not a chaperone.
Reason: GO:0031249 is being obsoleted and is inaccurate for Fbxo2 regardless. Fbxo2 does not bind denatured proteins in general -- it binds the N-glycan moiety on denatured glycoproteins. The enhanced binding to denatured vs native glycoproteins is because denaturation exposes the normally protein-buried chitobiose core of N-glycans. The actual molecular function is carbohydrate/oligosaccharide binding (already annotated as GO:0030246) and ubiquitin-like ligase-substrate adaptor activity (GO:1990756). Alternatively, GO:0051787 "misfolded protein binding" could apply in a loose sense, but this also misrepresents the mechanism since Fbxo2 recognizes the glycan, not the protein moiety. The best replacement is the oligosaccharide binding term combined with the substrate adaptor activity.
Proposed replacements:
oligosaccharide binding
ubiquitin-like ligase-substrate adaptor activity
Supporting Evidence:
PMID:15723043
Both Fbs1 and Fbs2 proteins interacted with denatured glycoproteins, which were modified with not only high-mannose but also complex-type oligosaccharides, more efficiently than native proteins. Given that Fbs proteins interact with innermost chitobiose in N-glycans, we propose that Fbs proteins distinguish native from unfolded glycoproteins by sensing the exposed chitobiose structure
|
|
GO:0036503
ERAD pathway
|
IDA
PMID:15723043 Glycoprotein-specific ubiquitin ligases recognize N-glycans ... |
ACCEPT |
Summary: IDA annotation for ERAD pathway from PMID:15723043. Redundant with IBA and IDA evidence from PMID:12140560, but independently confirmed.
Reason: Core function. PMID:15723043 confirmed ERAD involvement and additionally demonstrated the p97/VCP interaction that links Fbxo2 to the ERAD retrotranslocation machinery.
Supporting Evidence:
PMID:15723043
the SCF(Fbs1,2) ubiquitin-ligase complexes that contribute to ubiquitination of glycoproteins are involved in the ER-associated degradation pathway
|
|
GO:0001540
amyloid-beta binding
|
IDA
PMID:9173930 Identification of candidate proteins binding to prion protei... |
MARK AS OVER ANNOTATED |
Summary: IDA annotation for amyloid-beta binding from PMID:9173930 (Yehiely et al. 1997). This paper screened a lambdagt11 mouse brain cDNA library using a PrP-alkaline phosphatase fusion probe to find candidate prion protein binding partners. Six clones were isolated, four of which were novel. The paper identified Fbxo2 as a candidate prion protein binding partner, not specifically as an amyloid-beta binder. The annotation appears to be a misinterpretation of the screening result. The binding was to prion protein (PrP), not to amyloid-beta peptide.
Reason: PMID:9173930 was a candidate screen for PrP binding partners using a PrP-AP probe, not a specific amyloid-beta binding assay. The paper states it identified "candidate proteins binding to prion protein," not amyloid-beta. Given what is now known about Fbxo2's glycan-binding specificity, any interaction with PrP would most likely be mediated through PrP's N-glycans rather than specific amyloid-beta recognition. The annotation of "amyloid-beta binding" appears to be an overinterpretation. It is plausible that Fbxo2 could bind glycosylated forms of amyloid precursor protein (APP) family members through their N-glycans, but this would be glycan binding, not amyloid-beta peptide binding.
Supporting Evidence:
PMID:9173930
PrP-AP was used to screen a lambdagt11 mouse brain cDNA library, and six clones were isolated. Four cDNAs are novel while two clones are fragments of Nrf2 (NF-E2 related factor 2) transcription factor and Aplp1 (amyloid precursor-like protein 1)
|
|
GO:0030246
carbohydrate binding
|
IDA
PMID:12939278 Fbs2 is a new member of the E3 ubiquitin ligase family that ... |
ACCEPT |
Summary: IDA annotation for carbohydrate binding from PMID:12939278 (Yoshida et al. 2003). This paper primarily characterized Fbs2 (Fbxo6b) as a new family member, but also confirmed that Fbs1 (Fbxo2) binds specifically to proteins with high-mannose oligosaccharides. The paper demonstrated that Man3-9GlcNAc2 glycans are required for efficient binding.
Reason: Core molecular function. Carbohydrate binding (specifically N-glycan/oligosaccharide binding) is the primary mechanism by which Fbxo2 recognizes substrates. Well-supported by multiple papers including PMID:12140560, PMID:12939278, and structural studies (PMID:14990996, PMID:17389369).
Supporting Evidence:
PMID:12939278
Fbs1 (F-box protein that recognizes sugar chains; equivalent to Fbx2 or NFB42) binds specifically to proteins attached with high mannose oligosaccharides and subsequently contributes to elimination of N-glycoproteins in cytosol
|
|
GO:1990756
ubiquitin-like ligase-substrate adaptor activity
|
IDA
PMID:12140560 E3 ubiquitin ligase that recognizes sugar chains. |
NEW |
Summary: NEW annotation. Fbxo2 is the substrate-recognition (F-box) subunit of the SCF(Fbxo2) E3 ubiquitin ligase complex. It brings together the E3 ligase (via Skp1 binding through its F-box domain) and the glycoprotein substrate (via N-glycan binding through its FBA domain). This is the canonical function of F-box proteins. GO:1990756 is defined as "The binding activity of a molecule that brings together a ubiquitin-like ligase and its substrate. Usually mediated by F-box BTB/POZ domain proteins" -- this precisely describes Fbxo2.
Reason: This term is not currently annotated for Fbxo2 but is the most accurate molecular function descriptor. It captures the substrate adaptor role that is the core molecular function of Fbxo2, bridging the SCF complex catalytic machinery with glycoprotein substrates via N-glycan recognition. Supported by crystal structures (PMID:17389369) and biochemical data (PMID:12140560).
Supporting Evidence:
PMID:17389369
In SCF ubiquitin ligases, a diverse array of F-box proteins confers substrate specificity. Fbs1/Fbx2, a member of the F-box protein family, recognizes high-mannose oligosaccharides
PMID:12140560
The F-box protein Fbx2 (ref. 4) binds specifically to proteins attached to N-linked high-mannose oligosaccharides and subsequently contributes to ubiquitination of N-glycosylated proteins
|
|
GO:0070492
oligosaccharide binding
|
IDA
PMID:14990996 Structural basis of sugar-recognizing ubiquitin ligase. |
NEW |
Summary: NEW annotation. Fbxo2 specifically binds oligosaccharides, particularly Man3GlcNAc2 (the innermost core of N-glycans). This is more specific than the existing "carbohydrate binding" annotation. The crystal structure of Fbxo2 with chitobiose (PMID:14990996) and with glycoprotein substrate (PMID:17389369) demonstrated the oligosaccharide binding specificity.
Reason: GO:0070492 "oligosaccharide binding" is more specific than GO:0030246 "carbohydrate binding" and accurately describes Fbxo2's binding to N-glycan oligosaccharides. Mutagenesis of key residues (F177A, Y279A, W280A) abolished glycoprotein binding (PMID:14990996), confirming the structural basis of oligosaccharide recognition.
Supporting Evidence:
PMID:17389369
The structure of the SBD-glycoprotein complex indicates that the SBD primarily recognizes Man(3)GlcNAc(2), thereby explaining the broad activity of the enzyme against various glycoproteins
|
Q: Is Fbxo2's anti-aggregation function (suppressing aggregation of retrotranslocated glycoproteins in the cytosol, PMID:17215248) independent of its ubiquitin ligase activity, and does it warrant a separate GO annotation?
Q: Should the amyloid-beta binding annotation (GO:0001540, PMID:9173930) be removed entirely? The original paper identified Fbxo2 as a candidate PrP-binding protein, not an amyloid-beta binder. Any binding to PrP or APP family members is likely glycan-mediated.
Q: Would a more specific MF term like "N-glycan binding" or "high-mannose oligosaccharide binding" be appropriate for Fbxo2, rather than the general "carbohydrate binding"?
Experiment: Test whether Fbxo2 binds non-glycosylated misfolded proteins to definitively distinguish glycan-dependent vs protein-conformation-dependent recognition. This would clarify whether GO:0051787 (misfolded protein binding) is ever appropriate for Fbxo2.
Hypothesis: Fbxo2 does not bind non-glycosylated misfolded proteins because its binding mechanism is entirely glycan-dependent via the FBA domain.
Experiment: In Fbxo2 knockout cochlea, identify accumulated glycoprotein substrates by proteomics to better understand the ERAD substrates relevant to hearing loss pathogenesis (building on PMID:17494702).
Hypothesis: Specific cochlear glycoproteins accumulate in Fbxo2 knockout mice, revealing the ERAD substrates whose failed degradation causes cochlear degeneration.
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-09T23:08:38.919380'
end_time: '2026-02-09T23:15:59.379648'
duration_seconds: 440.46
template_file: templates/gene_research_go_focused.md
template_variables:
organism: mouse
gene_id: Fbxo2
gene_symbol: Fbxo2
uniprot_accession: Q80UW2
protein_description: 'RecName: Full=F-box only protein 2;'
gene_info: Name=Fbxo2; Synonyms=Fbs1, Fbx2;
organism_full: Mus musculus (Mouse).
protein_family: Not specified in UniProt
protein_domains: F-box-assoc_dom. (IPR007397); F-box-like_dom_sf. (IPR036047); F-box_dom.
(IPR001810); F-box_only. (IPR039752); Galactose-bd-like_sf. (IPR008979)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 25
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'Fbxo2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene Fbxo2 (gene ID: Fbxo2, UniProt: Q80UW2) in mouse.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Question: You are an expert researcher providing comprehensive, well-cited information.
Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies
Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.
BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.
DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'Fbxo2' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information
Please provide a comprehensive research report on the gene Fbxo2 (gene ID: Fbxo2, UniProt: Q80UW2) in mouse.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan and verification
- Identity check: The target is Fbxo2 (aliases: Fbs1, Fbx2; also reported as NFB42/OCP1/Fbg1 in older literature), encoding F-box only protein 2 in Mus musculus. Literature consistently describes an N-terminal F-box domain for SCF assembly and a C-terminal F-box-associated/substrate-binding domain (FBA/SBD) that recognizes the innermost N-glycan chitobiose/Man3GlcNAc2 core, in agreement with the UniProt Q80UW2 entry and the provided InterPro domains (F-box_dom, F-box-assoc/FBA, Galactose-binding-like superfamily) (nelson2007selectivecochleardegeneration pages 1-2, yoshida2007fboxproteinsthat pages 4-5, yoshida2007fboxproteinsthat pages 6-7). No conflicting gene symbols were found for a different gene in mouse.
| Aspect | Key details | Primary evidence (journal, year) | URL |
|---|---|---|---|
| Identity / aliases / organism | F-box only protein 2; aliases: Fbs1, Fbx2, NFB42, OCP1; organism: Mus musculus | The Journal of Neuroscience, 2007 (Nelson et al.) (nelson2007selectivecochleardegeneration pages 1-2) | https://doi.org/10.1523/jneurosci.0206-07.2007 |
| Domains / structure | N-terminal F-box; C-terminal F-box-associated substrate-binding domain (SBD/FBA); SBD is a β-sandwich with a small hydrophobic pocket contacting the innermost chitobiose; key pocket residues reported (e.g., Phe177, Tyr279, Trp280, Lys281 in mouse) | Bioscience, Biotechnology, and Biochemistry, 2007 (Yoshida) (yoshida2007fboxproteinsthat pages 4-5) | https://doi.org/10.1271/bbb.70074 |
| Biochemical function | Substrate receptor of SCF (Skp1–Cul1–F-box) E3 ubiquitin ligase; lectin-like recognition of the Man3GlcNAc2 core and preference for high-mannose N-glycans; mediates ubiquitination of glycoproteins for proteasomal degradation | Frontiers in Physiology, 2019 (Yoshida et al.) (yoshida2019sugarrecognizingubiquitinligases pages 1-2) | https://doi.org/10.3389/fphys.2019.00104 |
| Substrate specificity | Binds innermost N-glycan cores (Man3–9GlcNAc2) with highest affinity for high-mannose structures; preferentially recognizes denatured/unfolded glycoproteins where the inner glycan is exposed | Journal of Biological Chemistry, 2003 (Yoshida et al.) (yoshida2003fbs2isa pages 1-2) | https://doi.org/10.1074/jbc.m304157200 |
| Cellular localization | Nucleocytoplasmic / cytosolic F-box protein that interfaces with ERAD machinery at the ER membrane (associates functionally with p97 and retrotranslocation components) | Bioscience, Biotechnology, and Biochemistry, 2007 (Yoshida) (yoshida2007fboxproteinsthat pages 6-7) | https://doi.org/10.1271/bbb.70074 |
| Pathways | ER-associated degradation (ERAD) of misfolded N-glycoproteins; also functions in ubiquitin-mediated xenophagy by recognizing bacterial GlcNAc-containing surface glycans (e.g., GAS) to promote ubiquitin deposition and autophagic clearance | EMBO Reports, 2021 (Yamada et al.) (yamada2021fbxo2scfubiquitinligase pages 1-2) | https://doi.org/10.15252/embr.202152584 |
| In vivo phenotypes | Fbxo2−/− mice develop early-onset, progressive hearing loss with selective degeneration of cochlear epithelial support cells (later hair cells and spiral ganglion); brain largely spared despite CNS expression | The Journal of Neuroscience, 2007 (Nelson et al.) (nelson2007selectivecochleardegeneration pages 1-2) | https://doi.org/10.1523/jneurosci.0206-07.2007 |
| Applications | SBD/glycan-recognition properties enable affinity capture of N-glycans and N-glycopeptides and have motivated engineered high-affinity Fbs1-based reagents for glycoproteomics workflows | Bioscience, Biotechnology, and Biochemistry, 2007 (Yoshida) (yoshida2007fboxproteinsthat pages 4-5) | https://doi.org/10.1271/bbb.70074 |
Table: Compact summary table of FBXO2 (mouse Fbxo2/Fbs1) covering identity, domains, biochemical roles, specificity, localization, pathways, in vivo phenotype, and applied uses, with primary supporting citations for each aspect.
Comprehensive research report on mouse Fbxo2 (Fbs1/Fbx2; UniProt Q80UW2)
1) Key concepts and definitions (current understanding)
- Molecular identity and domain architecture: Fbxo2 encodes an F-box protein that serves as the substrate-recognition component of an SCF (Skp1–Cul1–Rbx1–F-box) E3 ubiquitin ligase. Its N-terminal F-box binds Skp1; its C-terminal substrate-binding domain (also called FBA/SBD) is a β-sandwich that engages the innermost chitobiose of N-linked glycans via a small hydrophobic pocket, with key pocket residues (mouse: Phe177, Tyr279, Trp280, Lys281) supporting glycan binding (Bioscience, Biotechnology, and Biochemistry, 2007; doi:10.1271/bbb.70074) (yoshida2007fboxproteinsthat pages 4-5, yoshida2007fboxproteinsthat pages 6-7).
- Primary biochemical function: FBXO2 is a lectin-type substrate adaptor that recognizes high-mannose N-glycans (especially the Man3GlcNAc2 core) on misfolded or unassembled glycoproteins and directs their ubiquitination by SCF for proteasomal degradation. This places FBXO2 in glycoprotein quality control, especially ER-associated degradation (ERAD), where retrotranslocated glycoproteins expose inner N-glycan moieties for recognition (Frontiers in Physiology, 2019; doi:10.3389/fphys.2019.00104) (yoshida2019sugarrecognizingubiquitinligases pages 1-2, yoshida2007fboxproteinsthat pages 2-3, yoshida2007fboxproteinsthat pages 1-1).
- Substrate specificity: FBXO2 binds innermost N-glycan cores, preferring high-mannose species (Man3–Man9GlcNAc2). Binding is stronger to denatured/unfolded glycoproteins, reflecting exposure of the inner chitobiose; it can interact with complex N-glycans when the glycoprotein is denatured (J. Biol. Chem., 2003; doi:10.1074/jbc.m304157200; Biosci. Biotechnol. Biochem., 2007; doi:10.1271/bbb.70074) (yoshida2003fbs2isa pages 1-2, yoshida2007fboxproteinsthat pages 4-5).
- Cellular localization and pathway context: Although glycoproteins reside in the secretory pathway, FBXO2 is a cytosolic/nucleocytoplasmic F-box protein that operates at the ERAD interface—recognizing retrotranslocated ER glycoproteins, coordinating with p97/VCP for extraction, and targeting them to the proteasome after deglycosylation by PNGase (Biosci. Biotechnol. Biochem., 2007; doi:10.1271/bbb.70074) (yoshida2007fboxproteinsthat pages 6-7, yoshida2007fboxproteinsthat pages 2-3).
2) Recent developments and latest research (prioritizing 2023–2024)
- We found limited 2023–2024 primary literature specifically expanding mouse Fbxo2 mechanism. However, the most recent high-quality advance extending FBXO2 function beyond ERAD is xenophagy of cytosolic bacteria (EMBO Reports, 2021; doi:10.15252/embr.202152584). In human cells, FBXO2 recognizes GlcNAc-containing surface polysaccharide (GAC) on Group A Streptococcus, recruits SCF components, promotes ubiquitin coating of bacteria, and facilitates xenophagy. This underscores a broader paradigm of glycan-driven substrate selection by FBXO2 in immunity (yamada2021fbxo2scfubiquitinligase pages 1-2). The field’s structural/biophysical foundation and ERAD roles remain anchored by earlier, well-cited work (2003–2019) (yoshida2019sugarrecognizingubiquitinligases pages 1-2, yoshida2003fbs2isa pages 1-2, yoshida2007fboxproteinsthat pages 6-7).
3) Current applications and real-world implementations
- Glycoproteomics affinity reagents: The FBXO2/Fbs1 SBD has been engineered into high-affinity variants for unbiased enrichment of N-linked glycopeptides. The GYR variant (Nature Communications, 2017; doi:10.1038/ncomms15487) achieved submicromolar Kd to core structures and enabled simultaneous determination of N-glycan composition and glycosites from complex samples (e.g., human serum), outperforming lectin-based enrichment (chen2017anengineeredhigh pages 1-2). Foundational work also documented practical purification of native FBXO2/Fbs1 using RNase B affinity and chitobiose elution, highlighting its utility as a glycan-binding tool (Biosci. Biotechnol. Biochem., 2007; doi:10.1271/bbb.70074) (yoshida2007fboxproteinsthat pages 3-4, yoshida2007fboxproteinsthat pages 4-5).
- Antiviral restriction: FBXO2 recognizes the high-mannose N-glycans on Epstein–Barr virus glycoprotein B (gB), targeting it for SCF-dependent ubiquitination and proteasomal degradation; FBXO2 depletion increases gB surface transport and enhances viral entry (PLOS Pathogens, 2018; doi:10.1371/journal.ppat.1007208) (zhang2018epsteinbarrvirusactivates pages 1-2, zhang2018epsteinbarrvirusactivates pages 2-5).
4) Expert opinions and analysis from authoritative sources
- Reviews synthesizing sugar-recognizing F-box proteins conclude that FBXO2 (with FBXO6) is a cytosolic lectin-type F-box that interprets the innermost N-glycan as a degradation signal, linking glycan structure to ERAD substrate selection. Structural studies define a β-sandwich SBD with a hydrophobic pocket contacting chitobiose, rationalizing specificity for Man3GlcNAc2 and preference for high-mannose glycans. These reviews emphasize the divergence of lectin-type F-box functions, with FBXO27 acting in lysophagy and FBXO2 in ERAD and, more recently, xenophagy (Frontiers in Physiology, 2019; Biosci. Biotechnol. Biochem., 2007; BioEssays, 2018; doi:10.3389/fphys.2019.00104; 10.1271/bbb.70074; 10.1002/bies.201700215) (yoshida2019sugarrecognizingubiquitinligases pages 1-2, yoshida2007fboxproteinsthat pages 4-5, yoshida2007fboxproteinsthat pages 6-7) (yoshida2019sugarrecognizingubiquitinligases pages 1-2, yoshida2007fboxproteinsthat pages 4-5, yoshida2007fboxproteinsthat pages 6-7, yoshida2007fboxproteinsthat pages 2-3).
5) Relevant statistics and data from recent studies
- Binding and enrichment performance (engineered FBXO2/Fbs1): Quantitative ITC from the engineered Fbs1 study showed Kd ~0.12–0.13 μM for core pentasaccharide motifs (M3N2/M3N2F) versus ~3.0 μM for a sialylglycopeptide, supporting core-preference and explaining efficient, relatively unbiased glycopeptide capture by the GYR variant (Nature Communications, 2017; doi:10.1038/ncomms15487) (chen2017anengineeredhigh pages 1-2).
- Xenophagy functional effect: FBXO2 knockout reduced ubiquitin accumulation on intracellular Group A Streptococcus and impaired xenophagic degradation, with SCF components (SKP1, CUL1, ROC1) required for ubiquitin-mediated xenophagy. These functional phenotypes document FBXO2’s contribution to antibacterial autophagy (EMBO Reports, 2021; doi:10.15252/embr.202152584) (yamada2021fbxo2scfubiquitinligase pages 1-2).
- In vivo phenotype in mouse: Fbxo2−/− mice exhibit early-onset, progressive hearing loss beginning around 2 months of age, with initial degeneration of organ of Corti supporting cells, later involving hair cells and spiral ganglion; CNS largely spared despite widespread expression. Cochlear FBXO2 binds Skp1 and is unusually abundant; cochlear Skp1 levels decline with Fbx2 loss, and connexin 26 levels change during degeneration (J. Neurosci., 2007; doi:10.1523/JNEUROSCI.0206-07.2007) (nelson2007selectivecochleardegeneration pages 1-2).
Mechanistic depth and pathways
- ERAD: FBXO2 recognizes high-mannose N-glycans on misfolded/unassembled glycoproteins retrotranslocated to the cytosol. SCF^FBXO2 mediates polyubiquitination; p97/VCP-associated extraction and PNGase-mediated deglycosylation precede proteasomal degradation (Biosci. Biotechnol. Biochem., 2007; doi:10.1271/bbb.70074; Frontiers in Physiology, 2019; doi:10.3389/fphys.2019.00104) (yoshida2007fboxproteinsthat pages 6-7, yoshida2019sugarrecognizingubiquitinligases pages 1-2).
- Substrates and specificity determinants: Inner-core recognition (chitobiose) underpins preference for high-mannose N-glycans; denaturation exposes cores enabling binding to even complex glycans. Site-directed mutagenesis of SBD pocket residues (Phe177, Tyr279, Trp280, Lys281) reduces/abolishes binding, mapping a specific hydrophobic pocket that governs glycan recognition (Biosci. Biotechnol. Biochem., 2007; doi:10.1271/bbb.70074) (yoshida2007fboxproteinsthat pages 6-7, yoshida2007fboxproteinsthat pages 4-5).
- Beyond ERAD: FBXO2 mediates ubiquitin-dependent xenophagy through GlcNAc recognition on bacterial surfaces (GAS), converging SCF-mediated ubiquitination with autophagic effectors (EMBO Reports, 2021; doi:10.15252/embr.202152584) (yamada2021fbxo2scfubiquitinligase pages 1-2). Viral restriction of EBV via gB degradation indicates FBXO2’s lectin activity surveils pathogen-associated high-mannose glycans (PLOS Pathogens, 2018; doi:10.1371/journal.ppat.1007208) (zhang2018epsteinbarrvirusactivates pages 1-2).
Subcellular localization and context of action
- FBXO2 is a cytosolic/nucleocytoplasmic lectin-type F-box protein that can assemble with Skp1–Cul1–Rbx1. In cochlea, an abundant Fbx2–Skp1 heterodimer and limited full SCF formation were reported, suggesting tissue-specific stoichiometry and potential noncanonical complexes. Functionally, FBXO2 acts at the ER–cytosol interface during ERAD and in the cytosol for xenophagic targeting (J. Neurosci., 2007; doi:10.1523/JNEUROSCI.0206-07.2007; Biosci. Biotechnol. Biochem., 2007; doi:10.1271/bbb.70074) (nelson2007selectivecochleardegeneration pages 1-2, yoshida2007fboxproteinsthat pages 6-7).
Selected primary examples and evidence
- ERAD substrates and neuronal quality control: Foundational studies showed Fbs1/FBXO2 binds high-mannose glycans on canonical ERAD substrates (e.g., TCRα via Fbs2; by analogy and in vitro assays for Fbs1), and can influence neuronal glycoprotein turnover (e.g., NMDA receptor NR1 in some contexts) as part of glycan-directed quality control (J. Biol. Chem., 2003; doi:10.1074/jbc.m304157200; Biosci. Biotechnol. Biochem., 2007; doi:10.1271/bbb.70074) (yoshida2003fbs2isa pages 1-2, yoshida2007fboxproteinsthat pages 3-4).
- Engineered SBDs as analytical tools: The engineered Fbs1 GYR variant improves capture of complex and high-mannose glycopeptides, enabling deep N-glycoproteomics from serum with reduced bias—demonstrating translational utility of FBXO2-derived domains in biomarker discovery workflows (Nat. Commun., 2017; doi:10.1038/ncomms15487) (chen2017anengineeredhigh pages 1-2).
- Host–pathogen interactions: FBXO2 restricts EBV infectivity by ubiquitinating high-mannose–glycosylated gB; loss of FBXO2 stabilizes gB and increases membrane fusion and entry (PLOS Pathogens, 2018; doi:10.1371/journal.ppat.1007208). Separately, FBXO2 promotes ubiquitin deposition on cytosolic Group A Streptococcus, facilitating xenophagy (EMBO Reports, 2021; doi:10.15252/embr.202152584) (zhang2018epsteinbarrvirusactivates pages 1-2, yamada2021fbxo2scfubiquitinligase pages 1-2).
Limitations and open questions
- Time- and tissue-resolved assembly of SCF^FBXO2 vs. FBXO2–Skp1 heterodimer in vivo remains to be mapped quantitatively across tissues (cochlear data suggest atypical stoichiometry) (J. Neurosci., 2007; doi:10.1523/JNEUROSCI.0206-07.2007) (nelson2007selectivecochleardegeneration pages 1-2).
- High-resolution structural data of full-length FBXO2 within SCF bound to glycoprotein substrates would refine mechanistic models beyond isolated SBD structures (Biosci. Biotechnol. Biochem., 2007; doi:10.1271/bbb.70074) (yoshida2007fboxproteinsthat pages 4-5, yoshida2007fboxproteinsthat pages 6-7).
Key references with URLs and dates
- Yoshida Y. F-box proteins that contain sugar-binding domains. Bioscience, Biotechnology, and Biochemistry. 2007 Nov;71:2623–2631. doi:10.1271/bbb.70074. URL: https://doi.org/10.1271/bbb.70074 (yoshida2007fboxproteinsthat pages 4-5, yoshida2007fboxproteinsthat pages 6-7, yoshida2007fboxproteinsthat pages 7-8, yoshida2007fboxproteinsthat pages 2-3, yoshida2007fboxproteinsthat pages 3-4).
- Yoshida Y, Mizushima T, Tanaka K. Sugar-Recognizing Ubiquitin Ligases: Action Mechanisms and Physiology. Frontiers in Physiology. 2019 Feb;10:104. doi:10.3389/fphys.2019.00104. URL: https://doi.org/10.3389/fphys.2019.00104 (yoshida2019sugarrecognizingubiquitinligases pages 1-2).
- Yoshida Y et al. Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar chains. Journal of Biological Chemistry. 2003 Oct;278:43877–43884. doi:10.1074/jbc.M304157200. URL: https://doi.org/10.1074/jbc.m304157200 (yoshida2003fbs2isa pages 1-2).
- Nelson RF et al. Selective Cochlear Degeneration in Mice Lacking Fbx2. The Journal of Neuroscience. 2007 May 9;27(19):5163–5171. doi:10.1523/JNEUROSCI.0206-07.2007. URL: https://doi.org/10.1523/jneurosci.0206-07.2007 (nelson2007selectivecochleardegeneration pages 1-2).
- Yamada A et al. FBXO2/SCF ligase directs xenophagy via bacterial surface glycan recognition. EMBO Reports. 2021 Sep;22(11):e52584. doi:10.15252/embr.202152584. URL: https://doi.org/10.15252/embr.202152584 (yamada2021fbxo2scfubiquitinligase pages 1-2).
- Zhang H-J et al. EBV activates FBXO2 to limit infectivity by degrading glycoprotein B. PLOS Pathogens. 2018 Jul;14(7):e1007208. doi:10.1371/journal.ppat.1007208. URL: https://doi.org/10.1371/journal.ppat.1007208 (zhang2018epsteinbarrvirusactivates pages 1-2, zhang2018epsteinbarrvirusactivates pages 2-5).
- Chen M et al. Engineered high-affinity Fbs1 for N-glycan/glycopeptide capture. Nature Communications. 2017 May 22;8:15487. doi:10.1038/ncomms15487. URL: https://doi.org/10.1038/ncomms15487 (chen2017anengineeredhigh pages 1-2).
Conclusion
Mouse Fbxo2 encodes a lectin-type F-box protein whose SBD specifically recognizes the inner core of N-linked glycans to target glycoproteins for SCF-mediated ubiquitination in ERAD. Structural studies define a β-sandwich pocket contacting chitobiose; mutagenesis pinpoints essential residues. Beyond ER quality control, FBXO2 participates in host defense (xenophagy; viral restriction) by recognizing pathogen glycans. In vivo, Fbxo2−/− mice exhibit early-onset, progressive hearing loss with selective cochlear degeneration. Engineered FBXO2-derived SBDs are now practical tools for glycoproteomics. Collectively, FBXO2 integrates glycan pattern recognition with ubiquitin signaling across proteostasis and immunity (yoshida2019sugarrecognizingubiquitinligases pages 1-2, yoshida2007fboxproteinsthat pages 6-7, yamada2021fbxo2scfubiquitinligase pages 1-2, zhang2018epsteinbarrvirusactivates pages 1-2, nelson2007selectivecochleardegeneration pages 1-2, chen2017anengineeredhigh pages 1-2).
References
(nelson2007selectivecochleardegeneration pages 1-2): Rick F. Nelson, Kevin A. Glenn, Yuzhou Zhang, Hsiang Wen, Tina Knutson, Cynthia M. Gouvion, Barbara K. Robinson, Zouping Zhou, Baoli Yang, Richard J. H. Smith, and Henry L. Paulson. Selective cochlear degeneration in mice lacking the f-box protein, fbx2, a glycoprotein-specific ubiquitin ligase subunit. The Journal of Neuroscience, 27:5163-5171, May 2007. URL: https://doi.org/10.1523/jneurosci.0206-07.2007, doi:10.1523/jneurosci.0206-07.2007. This article has 86 citations.
(yoshida2007fboxproteinsthat pages 4-5): Yukiko YOSHIDA. F-box proteins that contain sugar-binding domains. Bioscience, Biotechnology, and Biochemistry, 71:2623-2631, Nov 2007. URL: https://doi.org/10.1271/bbb.70074, doi:10.1271/bbb.70074. This article has 51 citations.
(yoshida2007fboxproteinsthat pages 6-7): Yukiko YOSHIDA. F-box proteins that contain sugar-binding domains. Bioscience, Biotechnology, and Biochemistry, 71:2623-2631, Nov 2007. URL: https://doi.org/10.1271/bbb.70074, doi:10.1271/bbb.70074. This article has 51 citations.
(yoshida2019sugarrecognizingubiquitinligases pages 1-2): Yukiko Yoshida, Tsunehiro Mizushima, and Keiji Tanaka. Sugar-recognizing ubiquitin ligases: action mechanisms and physiology. Frontiers in Physiology, Feb 2019. URL: https://doi.org/10.3389/fphys.2019.00104, doi:10.3389/fphys.2019.00104. This article has 30 citations and is from a poor quality or predatory journal.
(yoshida2003fbs2isa pages 1-2): Yukiko Yoshida, Fuminori Tokunaga, Tomoki Chiba, Kazuhiro Iwai, Keiji Tanaka, and Tadashi Tai. Fbs2 is a new member of the e3 ubiquitin ligase family that recognizes sugar chains*. Journal of Biological Chemistry, 278:43877-43884, Oct 2003. URL: https://doi.org/10.1074/jbc.m304157200, doi:10.1074/jbc.m304157200. This article has 216 citations and is from a domain leading peer-reviewed journal.
(yamada2021fbxo2scfubiquitinligase pages 1-2): Akihiro Yamada, Miyako Hikichi, Takashi Nozawa, and Ichiro Nakagawa. Fbxo2/scf ubiquitin ligase complex directs xenophagy through recognizing bacterial surface glycan. EMBO reports, Sep 2021. URL: https://doi.org/10.15252/embr.202152584, doi:10.15252/embr.202152584. This article has 28 citations and is from a highest quality peer-reviewed journal.
(yoshida2007fboxproteinsthat pages 2-3): Yukiko YOSHIDA. F-box proteins that contain sugar-binding domains. Bioscience, Biotechnology, and Biochemistry, 71:2623-2631, Nov 2007. URL: https://doi.org/10.1271/bbb.70074, doi:10.1271/bbb.70074. This article has 51 citations.
(yoshida2007fboxproteinsthat pages 1-1): Yukiko YOSHIDA. F-box proteins that contain sugar-binding domains. Bioscience, Biotechnology, and Biochemistry, 71:2623-2631, Nov 2007. URL: https://doi.org/10.1271/bbb.70074, doi:10.1271/bbb.70074. This article has 51 citations.
(chen2017anengineeredhigh pages 1-2): Minyong Chen, Xiaofeng Shi, Rebecca M. Duke, Cristian I. Ruse, Nan Dai, Christopher H. Taron, and James C. Samuelson. An engineered high affinity fbs1 carbohydrate binding protein for selective capture of n-glycans and n-glycopeptides. Nature Communications, May 2017. URL: https://doi.org/10.1038/ncomms15487, doi:10.1038/ncomms15487. This article has 52 citations and is from a highest quality peer-reviewed journal.
(yoshida2007fboxproteinsthat pages 3-4): Yukiko YOSHIDA. F-box proteins that contain sugar-binding domains. Bioscience, Biotechnology, and Biochemistry, 71:2623-2631, Nov 2007. URL: https://doi.org/10.1271/bbb.70074, doi:10.1271/bbb.70074. This article has 51 citations.
(zhang2018epsteinbarrvirusactivates pages 1-2): Hao-Jiong Zhang, Jinxiu Tian, Xue-Kang Qi, Tong Xiang, Gui-Ping He, Hua Zhang, Xibao Yu, Xiao Zhang, Bingchun Zhao, Qi-Sheng Feng, Ming-Yuan Chen, Mu-Sheng Zeng, Yi-Xin Zeng, and Lin Feng. Epstein-barr virus activates f-box protein fbxo2 to limit viral infectivity by targeting glycoprotein b for degradation. PLOS Pathogens, 14:e1007208, Jul 2018. URL: https://doi.org/10.1371/journal.ppat.1007208, doi:10.1371/journal.ppat.1007208. This article has 46 citations and is from a highest quality peer-reviewed journal.
(zhang2018epsteinbarrvirusactivates pages 2-5): Hao-Jiong Zhang, Jinxiu Tian, Xue-Kang Qi, Tong Xiang, Gui-Ping He, Hua Zhang, Xibao Yu, Xiao Zhang, Bingchun Zhao, Qi-Sheng Feng, Ming-Yuan Chen, Mu-Sheng Zeng, Yi-Xin Zeng, and Lin Feng. Epstein-barr virus activates f-box protein fbxo2 to limit viral infectivity by targeting glycoprotein b for degradation. PLOS Pathogens, 14:e1007208, Jul 2018. URL: https://doi.org/10.1371/journal.ppat.1007208, doi:10.1371/journal.ppat.1007208. This article has 46 citations and is from a highest quality peer-reviewed journal.
(yoshida2007fboxproteinsthat pages 7-8): Yukiko YOSHIDA. F-box proteins that contain sugar-binding domains. Bioscience, Biotechnology, and Biochemistry, 71:2623-2631, Nov 2007. URL: https://doi.org/10.1271/bbb.70074, doi:10.1271/bbb.70074. This article has 51 citations.
id: Q80UW2
gene_symbol: Fbxo2
product_type: PROTEIN
status: IN_PROGRESS
taxon:
id: NCBITaxon:10090
label: Mus musculus
description: >-
Fbxo2 (also known as Fbs1, Fbx2, NFB42) is the substrate-recognition component of the
SCF(Fbxo2) E3 ubiquitin-protein ligase complex (SKP1-CUL1-FBXO2-RBX1). It functions
primarily in the endoplasmic reticulum-associated degradation (ERAD) pathway, where it
recognizes and binds N-linked high-mannose oligosaccharides on misfolded glycoproteins
that have been retrotranslocated from the ER to the cytosol. The sugar-binding domain
(FBA domain) recognizes Man3GlcNAc2 (the innermost chitobiose core of N-glycans), and
binding is enhanced when glycoproteins are denatured because denaturation exposes the
normally buried chitobiose structure (PMID:15723043, PMID:14990996). Fbxo2 is NOT a
chaperone; it is a glycoprotein sensor that targets substrates for ubiquitination and
proteasomal degradation. It also prevents cytosolic aggregation of retrotranslocated
glycoproteins (PMID:17215248). In neurons, Fbxo2 mediates activity-dependent degradation
of NMDA receptor NR1 subunits at glutamatergic synapses (PMID:15809437). Expression is
enriched in brain and cochlea; Fbxo2 knockout mice develop progressive hearing loss due
to cochlear cell degeneration (PMID:17494702). Fbxo2 also associates with p97/VCP AAA
ATPase for substrate extraction from the ER membrane (PMID:15723043).
existing_annotations:
# ============================================================
# IBA annotations (phylogenetically inferred, GO_REF:0000033)
# ============================================================
- term:
id: GO:0036503
label: ERAD pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for involvement in the ERAD pathway. This is a core function of Fbxo2,
well-established by multiple experimental papers. Fbxo2 recognizes N-glycans on
misfolded glycoproteins retrotranslocated from the ER and promotes their ubiquitination
and proteasomal degradation (PMID:12140560, PMID:15723043).
action: ACCEPT
reason: >-
ERAD is the central biological pathway in which Fbxo2 operates. The IBA annotation is
consistent with direct experimental evidence from PMID:12140560 and PMID:15723043. The
phylogenetic inference is well-supported.
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
expression of the mutant Fbx2 Delta F, which lacks the F-box domain that is
essential for forming the SCF complex, appreciably blocks degradation of typical
substrates of the ER-associated degradation pathway
- reference_id: PMID:15723043
supporting_text: >-
the SCF(Fbs1,2) ubiquitin-ligase complexes that contribute to ubiquitination of
glycoproteins are involved in the ER-associated degradation pathway
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for cytoplasm localization. Fbxo2 operates in the cytosol, where it
recognizes retrotranslocated glycoproteins from the ER. More specifically it localizes
to the cytosol and to microsome membrane peripheral cytoplasmic side (UniProt).
action: ACCEPT
reason: >-
Cytoplasm is a correct general localization. The IBA is consistent with IDA evidence
for cytosol (PMID:12140560). The broader term cytoplasm is acceptable for an IBA.
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
Pre-integrin beta 1 is a target of Fbx2; these two proteins interact in the
cytosol after inhibition of the proteasome
- term:
id: GO:0006516
label: glycoprotein catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for involvement in glycoprotein catabolic process. This is a core
function. Fbxo2 promotes ubiquitination and subsequent proteasomal degradation of
N-glycosylated proteins (PMID:12140560, PMID:15723043).
action: ACCEPT
reason: >-
Glycoprotein catabolism is the downstream consequence of Fbxo2-mediated substrate
recognition and ubiquitination. Well-supported by direct experimental evidence.
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
SCF(Fbx2) ubiquitinates N-glycosylated proteins that are translocated from the
ER to the cytosol by the quality control mechanism
- term:
id: GO:0019005
label: SCF ubiquitin ligase complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for membership in the SCF ubiquitin ligase complex. Fbxo2 is the F-box
substrate recognition subunit of the SCF(Fbxo2) complex consisting of CUL1, RBX1,
SKP1, and FBXO2 (PMID:12140560, PMID:17389369).
action: ACCEPT
reason: >-
SCF complex membership is a core structural aspect of Fbxo2 function, extensively
validated by crystal structures (PMID:17389369) and biochemical data (PMID:12140560).
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
N-glycan serves as a signal for degradation by the Skp1-Cullin1-Fbx2-Roc1
(SCF(Fbx2)) ubiquitin ligase complex
- term:
id: GO:0031146
label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for involvement in SCF-dependent proteasomal ubiquitin-dependent
protein catabolic process. This describes the pathway Fbxo2 participates in.
action: ACCEPT
reason: >-
This is the specific proteasomal degradation pathway that SCF(Fbxo2) mediates.
Well-supported by PMID:12140560 demonstrating that SCF(Fbxo2) ubiquitinates
glycoproteins for proteasomal degradation.
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
The F-box protein Fbx2 (ref. 4) binds specifically to proteins attached to
N-linked high-mannose oligosaccharides and subsequently contributes to
ubiquitination of N-glycosylated proteins
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for ubiquitin protein ligase activity with qualifier "contributes_to".
Fbxo2 is the substrate recognition component of the SCF(Fbxo2) E3 ligase complex; it
does not itself possess catalytic E3 ligase activity but contributes to the complex's
activity by conferring substrate specificity (PMID:12140560, PMID:17389369).
action: MODIFY
reason: >-
While "contributes_to" ubiquitin protein ligase activity is technically defensible as
Fbxo2 is a subunit of an active E3 ligase complex, the more precise molecular function
of Fbxo2 is as a ubiquitin ligase substrate adaptor. GO:1990756 "ubiquitin-like
ligase-substrate adaptor activity" better captures Fbxo2's actual role: bringing
together the E3 ligase and its substrate through glycan recognition.
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:17389369
supporting_text: >-
In SCF ubiquitin ligases, a diverse array of F-box proteins confers substrate
specificity. Fbs1/Fbx2, a member of the F-box protein family, recognizes
high-mannose oligosaccharides
# ============================================================
# IEA annotations (electronic annotations)
# ============================================================
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for cytoplasm localization. Redundant with IBA and IDA evidence
for cytoplasm/cytosol localization.
action: ACCEPT
reason: >-
Correct and consistent with experimental evidence. IEA is broader than the IDA
cytosol annotation but not incorrect.
- term:
id: GO:0006516
label: glycoprotein catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA annotation for glycoprotein catabolic process, inferred by ARBA machine learning.
Redundant with IBA and IDA evidence for the same term.
action: ACCEPT
reason: >-
Correct and consistent with experimental data from PMID:12140560 and PMID:15723043.
- term:
id: GO:0019005
label: SCF ubiquitin ligase complex
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA annotation for SCF ubiquitin ligase complex membership. Redundant with IBA and
IDA evidence.
action: ACCEPT
reason: >-
Correct. Fbxo2 is a well-characterized component of the SCF(Fbxo2) complex.
- term:
id: GO:0030246
label: carbohydrate binding
evidence_type: IEA
original_reference_id: GO_REF:0000120
review:
summary: >-
IEA annotation for carbohydrate binding, inferred from UniProt keyword "Lectin".
Carbohydrate binding is a core molecular function of Fbxo2. The FBA (F-box associated)
domain specifically binds high-mannose N-glycans (PMID:14990996, PMID:17389369).
action: ACCEPT
reason: >-
Correct and a core function. Carbohydrate binding is well-established experimentally.
While a more specific term like oligosaccharide binding (GO:0070492) might be more
precise, carbohydrate binding is not incorrect for an IEA annotation.
- term:
id: GO:0031146
label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA annotation for SCF-dependent proteasomal degradation. Redundant with IBA and IDA
evidence for the same term.
action: ACCEPT
reason: >-
Correct and consistent with experimental evidence from PMID:12140560.
- term:
id: GO:0036503
label: ERAD pathway
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA annotation for ERAD pathway involvement. Redundant with IBA and IDA evidence.
action: ACCEPT
reason: >-
Correct. ERAD is the core biological pathway of Fbxo2 function.
# ============================================================
# IPI annotations (protein binding, various references)
# ============================================================
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17389369
review:
summary: >-
IPI annotation for protein binding based on crystal structure of SCF(Fbs1) with
glycoprotein substrate RNase1 (PMID:17389369). The interaction partner is
UniProtKB:P61823 (bovine RNase1). The crystal structure revealed the structural
basis for how the sugar-binding domain selects glycosylated substrates.
action: MODIFY
reason: >-
"Protein binding" is uninformative. The interaction demonstrated in PMID:17389369 is
actually glycan-mediated binding of a glycoprotein substrate. The correct MF annotation
is carbohydrate binding or more specifically oligosaccharide binding, or the substrate
adaptor activity. Since these are already captured by other annotations, this particular
"protein binding" annotation should be modified to the more informative substrate adaptor
term.
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:17389369
supporting_text: >-
The structure of the SBD-glycoprotein complex indicates that the SBD primarily
recognizes Man(3)GlcNAc(2), thereby explaining the broad activity of the enzyme
against various glycoproteins
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17389369
review:
summary: >-
Second IPI annotation for protein binding from PMID:17389369, this time with
UniProtKB:P63208-1 (Skp1). The crystal structure showed the Skp1-Fbs1 complex
architecture with the F-box domain mediating Skp1 interaction.
action: MODIFY
reason: >-
"Protein binding" is uninformative. The interaction with Skp1 is an obligate
structural interaction within the SCF complex. This is better captured by the
existing SCF complex membership annotation (GO:0019005) and the substrate adaptor
activity (GO:1990756).
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:17389369
supporting_text: >-
we determined the crystal structures of the Skp1-Fbs1 complex and the
sugar-binding domain (SBD) of the Fbs1-glycoprotein complex
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15809437
review:
summary: >-
IPI annotation for protein binding based on PMID:15809437, with interaction partner
PR:P35438 (NR1/GRIN1 NMDA receptor subunit). Fbxo2 binds to high-mannose glycans
of the NR1 ectodomain and promotes NR1 ubiquitination.
action: MODIFY
reason: >-
"Protein binding" is uninformative. The binding to NR1 is glycan-mediated (Fbxo2
binds the high-mannose glycans on the NR1 ectodomain) and represents substrate
recognition for ubiquitination. This is better captured by carbohydrate binding
(GO:0030246) and/or ubiquitin-like ligase-substrate adaptor activity (GO:1990756).
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
the F-box protein, Fbx2, bound to high-mannose glycans of the NR1 ectodomain.
F-box proteins specify ubiquitination by linking protein substrates to the
terminal E3 ligase
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15723043
review:
summary: >-
IPI annotation for protein binding from PMID:15723043, with interaction partner
PR:P09055 (integrin beta-1). Fbxo2 interacts with integrin-beta1 (an ERAD substrate)
in the cytosol in a manner dependent on p97 ATPase activity.
action: MODIFY
reason: >-
"Protein binding" is uninformative. The interaction with integrin-beta1 represents
glycan-mediated substrate recognition. This is better captured by the substrate
adaptor activity term and the ERAD pathway annotation.
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
The SCF(Fbs1) complex was associated with p97/VCP AAA ATPase and bound to
integrin-beta1, one of the SCF(Fbs1) substrates, in the cytosol in a manner
dependent on p97 ATPase activity
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15723043
review:
summary: >-
Second IPI annotation for protein binding from PMID:15723043 (with PR:Q01853, VCP/p97).
This is a separate entry from the same reference, representing the VCP/p97 interaction
partner.
action: MODIFY
reason: >-
Same reasoning as the other PMID:15723043 protein binding annotation. The VCP/p97
interaction is part of the ERAD machinery. "Protein binding" is uninformative; the
ERAD pathway annotation already captures this functional context.
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
The SCF(Fbs1) complex was associated with p97/VCP AAA ATPase
# ============================================================
# ISO annotations (ortholog-based transfer)
# ============================================================
- term:
id: GO:0005737
label: cytoplasm
evidence_type: ISO
original_reference_id: GO_REF:0000119
review:
summary: >-
ISO annotation for cytoplasm localization, transferred from human ortholog
UniProtKB:Q9UK22 (FBXO2). Redundant with IBA and IDA evidence.
action: ACCEPT
reason: >-
Correct and consistent with experimental evidence for cytoplasm/cytosol localization.
- term:
id: GO:0008285
label: negative regulation of cell population proliferation
evidence_type: ISO
original_reference_id: GO_REF:0000096
review:
summary: >-
ISO annotation for negative regulation of cell population proliferation, transferred
from rat ortholog RGD:621751. This is not a well-characterized function of Fbxo2.
The core function of Fbxo2 is ERAD-linked glycoprotein degradation, not cell
proliferation regulation.
action: KEEP_AS_NON_CORE
reason: >-
While Fbxo2-mediated degradation of glycoprotein substrates could indirectly affect
cell proliferation, this is not a core evolved function. The annotation is based on
ortholog transfer from rat and may reflect a secondary/downstream consequence of
Fbxo2's ubiquitin ligase activity rather than a specific proliferation-regulatory role.
Keeping as non-core since the evidence is indirect.
- term:
id: GO:0098890
label: extrinsic component of postsynaptic membrane
evidence_type: ISO
original_reference_id: GO_REF:0000096
review:
summary: >-
ISO annotation for extrinsic component of postsynaptic membrane, transferred from
rat ortholog. This is consistent with Fbxo2's role in degrading NMDA receptor NR1
subunits at the postsynapse (PMID:15809437).
action: ACCEPT
reason: >-
This localization is consistent with the experimentally demonstrated role of Fbxo2
at glutamatergic synapses (PMID:15809437). Fbxo2 acts on NR1 subunits at the
postsynaptic membrane, and being a cytoplasmic peripheral protein would make it an
extrinsic component of the postsynaptic membrane.
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
the F-box protein, Fbx2, bound to high-mannose glycans of the NR1 ectodomain
- term:
id: GO:0098978
label: glutamatergic synapse
evidence_type: ISO
original_reference_id: GO_REF:0000096
review:
summary: >-
ISO annotation for glutamatergic synapse localization, transferred from rat ortholog.
Redundant with IDA evidence from SynGO (PMID:15809437).
action: ACCEPT
reason: >-
Correct. Fbxo2 localizes to glutamatergic synapses where it mediates NMDA receptor
degradation. Consistent with direct experimental evidence from PMID:15809437.
# ============================================================
# IDA annotations from SynGO (PMID:15809437) - glutamatergic synapse
# Multiple ECO codes for the same term represent different evidence types
# ============================================================
- term:
id: GO:0098978
label: glutamatergic synapse
evidence_type: IDA
original_reference_id: PMID:15809437
review:
summary: >-
IDA annotation from SynGO for glutamatergic synapse localization based on
PMID:15809437. Kato et al. showed Fbxo2 localizes to hippocampal neurons and
specifically targets NR1 at glutamatergic synapses. Multiple evidence lines
(ECO:0000314, ECO:0005589, ECO:0007695, ECO:0007719) all support this.
action: ACCEPT
reason: >-
Well-supported by PMID:15809437 which demonstrated Fbxo2 localization and function
at glutamatergic synapses in hippocampal neurons.
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
When expressed in hippocampal neurons, this Fbx2 dominant-negative mutant
augmented NR1 subunit levels and NMDA receptor-mediated currents in an
activity-dependent fashion
- term:
id: GO:0098978
label: glutamatergic synapse
evidence_type: IMP
original_reference_id: PMID:15809437
review:
summary: >-
IMP annotation from SynGO for glutamatergic synapse localization based on mutant
phenotype analysis (dominant-negative Fbxo2) in PMID:15809437.
action: ACCEPT
reason: >-
The dominant-negative Fbxo2 mutant increased NR1 levels and NMDA receptor currents
at glutamatergic synapses, demonstrating that endogenous Fbxo2 functions at these
synapses (PMID:15809437).
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
this Fbx2 dominant-negative mutant augmented NR1 subunit levels and NMDA
receptor-mediated currents in an activity-dependent fashion
# ============================================================
# IDA annotations from SynGO (PMID:15809437) - synaptic protein catabolism
# ============================================================
- term:
id: GO:0099576
label: regulation of protein catabolic process at postsynapse, modulating synaptic
transmission
evidence_type: IDA
original_reference_id: PMID:15809437
review:
summary: >-
IDA annotation from SynGO for regulation of postsynaptic protein catabolism. Fbxo2
promotes ubiquitination and degradation of NMDA receptor NR1 subunits at the
postsynapse, thereby modulating synaptic transmission (PMID:15809437).
action: ACCEPT
reason: >-
This is a well-supported neuronal-specific function of Fbxo2. Kato et al. showed that
Fbxo2 mediates activity-dependent NR1 degradation at postsynaptic sites, directly
modulating NMDA receptor-mediated currents.
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
ubiquitination of NR1 was increased by Fbx2 and diminished by an Fbx2
dominant-negative mutant
- term:
id: GO:0099576
label: regulation of protein catabolic process at postsynapse, modulating synaptic
transmission
evidence_type: IMP
original_reference_id: PMID:15809437
review:
summary: >-
IMP annotation from SynGO for postsynaptic protein catabolism regulation, based on
mutant phenotype evidence. The dominant-negative Fbxo2 augmented NR1 levels and
NMDA receptor currents.
action: ACCEPT
reason: >-
Well-supported by the dominant-negative experiment in PMID:15809437 showing
that blocking Fbxo2 function increased NR1 levels and NMDA receptor currents.
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
this Fbx2 dominant-negative mutant augmented NR1 subunit levels and NMDA
receptor-mediated currents in an activity-dependent fashion
# ============================================================
# IEA annotation - protein ubiquitination (UniPathway)
# ============================================================
- term:
id: GO:0016567
label: protein ubiquitination
evidence_type: IEA
original_reference_id: GO_REF:0000041
review:
summary: >-
IEA annotation for protein ubiquitination, based on UniPathway vocabulary mapping.
Fbxo2 participates in protein ubiquitination as part of the SCF(Fbxo2) complex.
action: ACCEPT
reason: >-
Correct. Fbxo2 is integral to the SCF(Fbxo2) E3 ubiquitin ligase complex that
ubiquitinates glycoprotein substrates. Consistent with IDA evidence from PMID:12140560.
# ============================================================
# IPI annotation - protein binding (PMID:15809437, from MGI)
# ============================================================
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15809437
review:
summary: >-
IPI annotation for protein binding from PMID:15809437, with interaction partner
PR:P35438 (NR1/GRIN1). This is the MGI-curated version of the NR1 interaction.
Redundant with the SynGO-curated IPI annotation from the same paper.
action: MODIFY
reason: >-
"Protein binding" is uninformative. The NR1 interaction is glycan-mediated and
represents substrate recognition for ubiquitination. Better captured by
GO:1990756 ubiquitin-like ligase-substrate adaptor activity.
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
the F-box protein, Fbx2, bound to high-mannose glycans of the NR1 ectodomain
# ============================================================
# IDA annotations from UniProtKB (PMID:12140560) - original Yoshida 2002 paper
# ============================================================
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: PMID:12140560
review:
summary: >-
IDA annotation for cytosol localization from the landmark paper identifying
SCF(Fbxo2) (PMID:12140560). Fbxo2 interacts with its glycoprotein substrate
pre-integrin beta-1 in the cytosol after proteasome inhibition.
action: ACCEPT
reason: >-
Well-supported. Yoshida et al. demonstrated cytosolic localization of Fbxo2 and
its interaction with substrates in the cytosol (PMID:12140560). UniProt also lists
cytoplasm and microsome membrane (cytoplasmic side) as subcellular locations.
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
Pre-integrin beta 1 is a target of Fbx2; these two proteins interact in the
cytosol after inhibition of the proteasome
- term:
id: GO:0006516
label: glycoprotein catabolic process
evidence_type: IDA
original_reference_id: PMID:12140560
review:
summary: >-
IDA annotation for glycoprotein catabolic process from PMID:12140560. SCF(Fbxo2)
ubiquitinates N-glycosylated proteins translocated from the ER, promoting their
proteasomal degradation.
action: ACCEPT
reason: >-
Core function. Directly demonstrated in PMID:12140560 that Fbxo2 targets glycoproteins
for degradation.
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
SCF(Fbx2) ubiquitinates N-glycosylated proteins that are translocated from the
ER to the cytosol by the quality control mechanism
- term:
id: GO:0016567
label: protein ubiquitination
evidence_type: IDA
original_reference_id: PMID:12140560
review:
summary: >-
IDA annotation for protein ubiquitination from PMID:12140560. Fbxo2 contributes to
ubiquitination of N-glycosylated proteins as part of the SCF(Fbxo2) complex.
action: ACCEPT
reason: >-
Core function. Directly demonstrated in PMID:12140560.
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
The F-box protein Fbx2 (ref. 4) binds specifically to proteins attached to
N-linked high-mannose oligosaccharides and subsequently contributes to
ubiquitination of N-glycosylated proteins
- term:
id: GO:0019005
label: SCF ubiquitin ligase complex
evidence_type: IDA
original_reference_id: PMID:12140560
review:
summary: >-
IDA annotation for SCF ubiquitin ligase complex membership from PMID:12140560.
Fbxo2 was identified as the F-box protein forming the SCF(Fbxo2) complex
(SKP1-CUL1-FBXO2-ROC1).
action: ACCEPT
reason: >-
Core structural annotation. The SCF(Fbxo2) complex was originally identified in
PMID:12140560 and confirmed by crystal structures (PMID:17389369).
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
N-glycan serves as a signal for degradation by the Skp1-Cullin1-Fbx2-Roc1
(SCF(Fbx2)) ubiquitin ligase complex
- term:
id: GO:0031146
label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
evidence_type: IDA
original_reference_id: PMID:12140560
review:
summary: >-
IDA annotation for SCF-dependent proteasomal degradation from PMID:12140560.
SCF(Fbxo2) mediates ubiquitin-dependent proteasomal degradation of glycoprotein
substrates.
action: ACCEPT
reason: >-
Core function. The dominant-negative Fbxo2 Delta-F blocked ERAD substrate
degradation (PMID:12140560), directly demonstrating SCF-dependent proteasomal
degradation.
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
expression of the mutant Fbx2 Delta F, which lacks the F-box domain that is
essential for forming the SCF complex, appreciably blocks degradation of typical
substrates of the ER-associated degradation pathway
# ============================================================
# IDA annotations from MGI (PMID:15723043) - Yoshida 2005
# ============================================================
- term:
id: GO:0006511
label: ubiquitin-dependent protein catabolic process
evidence_type: IDA
original_reference_id: PMID:15723043
review:
summary: >-
IDA annotation for ubiquitin-dependent protein catabolic process from PMID:15723043.
This is a parent term of the more specific SCF-dependent proteasomal degradation
annotation. Fbxo2 mediates ubiquitin-dependent degradation of glycoprotein substrates.
action: ACCEPT
reason: >-
Correct, though redundant with the more specific GO:0031146 annotation. Keeping as
the evidence from PMID:15723043 demonstrated ubiquitin-dependent degradation.
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
the SCF(Fbs1,2) ubiquitin-ligase complexes that contribute to ubiquitination of
glycoproteins are involved in the ER-associated degradation pathway
# ============================================================
# IDA annotations from MGI (PMID:15809437) - Kato 2005
# ============================================================
- term:
id: GO:0031396
label: regulation of protein ubiquitination
evidence_type: IDA
original_reference_id: PMID:15809437
review:
summary: >-
IDA annotation for regulation of protein ubiquitination from PMID:15809437. Fbxo2
increased NR1 ubiquitination, and the dominant-negative mutant diminished it.
action: ACCEPT
reason: >-
Well-supported. PMID:15809437 showed that Fbxo2 expression increased NR1
ubiquitination and the dominant-negative form decreased it, demonstrating regulation
of ubiquitination at the synapse.
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
ubiquitination of NR1 was increased by Fbx2 and diminished by an Fbx2
dominant-negative mutant
- term:
id: GO:0043197
label: dendritic spine
evidence_type: IDA
original_reference_id: PMID:15809437
review:
summary: >-
IDA annotation for dendritic spine localization from PMID:15809437. Fbxo2 was shown
to localize to hippocampal neurons including dendritic spines where it targets NMDA
receptors for degradation.
action: ACCEPT
reason: >-
Consistent with the synaptic function of Fbxo2 in degrading NR1 subunits. Dendritic
spines are the postsynaptic compartment of glutamatergic synapses.
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
When expressed in hippocampal neurons, this Fbx2 dominant-negative mutant
augmented NR1 subunit levels and NMDA receptor-mediated currents
# ============================================================
# TAS and IDA annotations from MGI (PMID:15723043)
# ============================================================
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:15723043
review:
summary: >-
IPI annotation for protein binding from PMID:15723043, with interaction partner
PR:Q01853 (VCP/p97). This is the MGI-curated record of Fbxo2 interaction with
VCP/p97 AAA ATPase.
action: MODIFY
reason: >-
"Protein binding" is uninformative. The VCP/p97 interaction is part of the ERAD
machinery coordination. Better captured by ERAD pathway annotation.
proposed_replacement_terms:
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
The SCF(Fbs1) complex was associated with p97/VCP AAA ATPase and bound to
integrin-beta1, one of the SCF(Fbs1) substrates, in the cytosol in a manner
dependent on p97 ATPase activity
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: PMID:15723043
review:
summary: >-
TAS annotation for cytosol localization from PMID:15723043. Yoshida et al. showed
Fbxo2 binds integrin-beta1 in the cytosol dependent on p97 ATPase activity.
action: ACCEPT
reason: >-
Correct and consistent with IDA evidence from PMID:12140560. Redundant but valid.
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
The SCF(Fbs1) complex was associated with p97/VCP AAA ATPase and bound to
integrin-beta1, one of the SCF(Fbs1) substrates, in the cytosol
- term:
id: GO:0006516
label: glycoprotein catabolic process
evidence_type: IDA
original_reference_id: PMID:15723043
review:
summary: >-
IDA annotation for glycoprotein catabolic process from PMID:15723043. Redundant with
the same annotation from PMID:12140560, but independently supported by this paper
which demonstrated Fbs1/Fbs2 interaction with denatured glycoproteins.
action: ACCEPT
reason: >-
Core function, independently confirmed in PMID:15723043.
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
the SCF(Fbs1,2) ubiquitin-ligase complexes that contribute to ubiquitination
of glycoproteins are involved in the ER-associated degradation pathway
# ============================================================
# KEY ANNOTATION: denatured protein binding (GO:0031249)
# This is the annotation being obsoleted as part of this project
# ============================================================
- term:
id: GO:0031249
label: denatured protein binding
evidence_type: IDA
original_reference_id: PMID:15723043
review:
summary: >-
IDA annotation for denatured protein binding. GO:0031249 is being obsoleted. Yoshida
et al. (PMID:15723043) showed that Fbs1 and Fbs2 "interacted with denatured
glycoproteins...more efficiently than native proteins" and proposed that "Fbs proteins
distinguish native from unfolded glycoproteins by sensing the exposed chitobiose
structure." Critically, this is NOT general denatured protein binding. Fbxo2 recognizes
the N-glycan (chitobiose core) that becomes exposed upon glycoprotein denaturation.
It does not bind non-glycosylated denatured proteins and is not a chaperone.
action: MODIFY
reason: >-
GO:0031249 is being obsoleted and is inaccurate for Fbxo2 regardless. Fbxo2 does not
bind denatured proteins in general -- it binds the N-glycan moiety on denatured
glycoproteins. The enhanced binding to denatured vs native glycoproteins is because
denaturation exposes the normally protein-buried chitobiose core of N-glycans. The
actual molecular function is carbohydrate/oligosaccharide binding (already annotated
as GO:0030246) and ubiquitin-like ligase-substrate adaptor activity (GO:1990756).
Alternatively, GO:0051787 "misfolded protein binding" could apply in a loose sense,
but this also misrepresents the mechanism since Fbxo2 recognizes the glycan, not the
protein moiety. The best replacement is the oligosaccharide binding term combined with
the substrate adaptor activity.
proposed_replacement_terms:
- id: GO:0070492
label: oligosaccharide binding
- id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
Both Fbs1 and Fbs2 proteins interacted with denatured glycoproteins, which were
modified with not only high-mannose but also complex-type oligosaccharides, more
efficiently than native proteins. Given that Fbs proteins interact with innermost
chitobiose in N-glycans, we propose that Fbs proteins distinguish native from
unfolded glycoproteins by sensing the exposed chitobiose structure
# ============================================================
# IDA annotation for ERAD pathway from MGI (PMID:15723043)
# ============================================================
- term:
id: GO:0036503
label: ERAD pathway
evidence_type: IDA
original_reference_id: PMID:15723043
review:
summary: >-
IDA annotation for ERAD pathway from PMID:15723043. Redundant with IBA and IDA
evidence from PMID:12140560, but independently confirmed.
action: ACCEPT
reason: >-
Core function. PMID:15723043 confirmed ERAD involvement and additionally demonstrated
the p97/VCP interaction that links Fbxo2 to the ERAD retrotranslocation machinery.
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
the SCF(Fbs1,2) ubiquitin-ligase complexes that contribute to ubiquitination of
glycoproteins are involved in the ER-associated degradation pathway
# ============================================================
# IDA annotation for amyloid-beta binding (PMID:9173930)
# ============================================================
- term:
id: GO:0001540
label: amyloid-beta binding
evidence_type: IDA
original_reference_id: PMID:9173930
review:
summary: >-
IDA annotation for amyloid-beta binding from PMID:9173930 (Yehiely et al. 1997).
This paper screened a lambdagt11 mouse brain cDNA library using a PrP-alkaline
phosphatase fusion probe to find candidate prion protein binding partners. Six
clones were isolated, four of which were novel. The paper identified Fbxo2 as a
candidate prion protein binding partner, not specifically as an amyloid-beta binder.
The annotation appears to be a misinterpretation of the screening result. The binding
was to prion protein (PrP), not to amyloid-beta peptide.
action: MARK_AS_OVER_ANNOTATED
reason: >-
PMID:9173930 was a candidate screen for PrP binding partners using a PrP-AP probe,
not a specific amyloid-beta binding assay. The paper states it identified "candidate
proteins binding to prion protein," not amyloid-beta. Given what is now known about
Fbxo2's glycan-binding specificity, any interaction with PrP would most likely be
mediated through PrP's N-glycans rather than specific amyloid-beta recognition. The
annotation of "amyloid-beta binding" appears to be an overinterpretation. It is
plausible that Fbxo2 could bind glycosylated forms of amyloid precursor protein (APP)
family members through their N-glycans, but this would be glycan binding, not
amyloid-beta peptide binding.
supported_by:
- reference_id: PMID:9173930
supporting_text: >-
PrP-AP was used to screen a lambdagt11 mouse brain cDNA library, and six clones
were isolated. Four cDNAs are novel while two clones are fragments of Nrf2
(NF-E2 related factor 2) transcription factor and Aplp1 (amyloid precursor-like
protein 1)
# ============================================================
# IDA annotation for carbohydrate binding (PMID:12939278)
# ============================================================
- term:
id: GO:0030246
label: carbohydrate binding
evidence_type: IDA
original_reference_id: PMID:12939278
review:
summary: >-
IDA annotation for carbohydrate binding from PMID:12939278 (Yoshida et al. 2003).
This paper primarily characterized Fbs2 (Fbxo6b) as a new family member, but also
confirmed that Fbs1 (Fbxo2) binds specifically to proteins with high-mannose
oligosaccharides. The paper demonstrated that Man3-9GlcNAc2 glycans are required for
efficient binding.
action: ACCEPT
reason: >-
Core molecular function. Carbohydrate binding (specifically N-glycan/oligosaccharide
binding) is the primary mechanism by which Fbxo2 recognizes substrates. Well-supported
by multiple papers including PMID:12140560, PMID:12939278, and structural studies
(PMID:14990996, PMID:17389369).
supported_by:
- reference_id: PMID:12939278
supporting_text: >-
Fbs1 (F-box protein that recognizes sugar chains; equivalent to Fbx2 or NFB42)
binds specifically to proteins attached with high mannose oligosaccharides and
subsequently contributes to elimination of N-glycoproteins in cytosol
# ============================================================
# NEW annotations suggested based on literature review
# ============================================================
- term:
id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
evidence_type: IDA
original_reference_id: PMID:12140560
review:
summary: >-
NEW annotation. Fbxo2 is the substrate-recognition (F-box) subunit of the SCF(Fbxo2)
E3 ubiquitin ligase complex. It brings together the E3 ligase (via Skp1 binding through
its F-box domain) and the glycoprotein substrate (via N-glycan binding through its FBA
domain). This is the canonical function of F-box proteins. GO:1990756 is defined as
"The binding activity of a molecule that brings together a ubiquitin-like ligase and its
substrate. Usually mediated by F-box BTB/POZ domain proteins" -- this precisely describes
Fbxo2.
action: NEW
reason: >-
This term is not currently annotated for Fbxo2 but is the most accurate molecular
function descriptor. It captures the substrate adaptor role that is the core molecular
function of Fbxo2, bridging the SCF complex catalytic machinery with glycoprotein
substrates via N-glycan recognition. Supported by crystal structures (PMID:17389369)
and biochemical data (PMID:12140560).
supported_by:
- reference_id: PMID:17389369
supporting_text: >-
In SCF ubiquitin ligases, a diverse array of F-box proteins confers substrate
specificity. Fbs1/Fbx2, a member of the F-box protein family, recognizes
high-mannose oligosaccharides
- reference_id: PMID:12140560
supporting_text: >-
The F-box protein Fbx2 (ref. 4) binds specifically to proteins attached to
N-linked high-mannose oligosaccharides and subsequently contributes to
ubiquitination of N-glycosylated proteins
- term:
id: GO:0070492
label: oligosaccharide binding
evidence_type: IDA
original_reference_id: PMID:14990996
review:
summary: >-
NEW annotation. Fbxo2 specifically binds oligosaccharides, particularly
Man3GlcNAc2 (the innermost core of N-glycans). This is more specific than the
existing "carbohydrate binding" annotation. The crystal structure of Fbxo2 with
chitobiose (PMID:14990996) and with glycoprotein substrate (PMID:17389369)
demonstrated the oligosaccharide binding specificity.
action: NEW
reason: >-
GO:0070492 "oligosaccharide binding" is more specific than GO:0030246 "carbohydrate
binding" and accurately describes Fbxo2's binding to N-glycan oligosaccharides.
Mutagenesis of key residues (F177A, Y279A, W280A) abolished glycoprotein binding
(PMID:14990996), confirming the structural basis of oligosaccharide recognition.
additional_reference_ids:
- PMID:17389369
supported_by:
- reference_id: PMID:17389369
supporting_text: >-
The structure of the SBD-glycoprotein complex indicates that the SBD primarily
recognizes Man(3)GlcNAc(2), thereby explaining the broad activity of the enzyme
against various glycoproteins
references:
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000096
title: Automated transfer of experimentally-verified manual GO annotation data to
mouse-rat orthologs
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000119
title: Automated transfer of experimentally-verified manual GO annotation data to
mouse-human orthologs
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:12140560
title: E3 ubiquitin ligase that recognizes sugar chains.
findings:
- statement: >-
SCF(Fbxo2) ubiquitin ligase complex identified as recognizing N-glycan sugar chains
on retrotranslocated glycoproteins for ERAD-mediated proteasomal degradation.
supporting_text: >-
N-glycan serves as a signal for degradation by the Skp1-Cullin1-Fbx2-Roc1
(SCF(Fbx2)) ubiquitin ligase complex
- statement: >-
Pre-integrin beta-1 identified as substrate of SCF(Fbxo2); interaction occurs in
cytosol after proteasome inhibition.
supporting_text: >-
Pre-integrin beta 1 is a target of Fbx2; these two proteins interact in the
cytosol after inhibition of the proteasome
- statement: >-
Dominant-negative Fbxo2 (lacking F-box domain) blocks typical ERAD substrate
degradation.
supporting_text: >-
expression of the mutant Fbx2 Delta F, which lacks the F-box domain that is
essential for forming the SCF complex, appreciably blocks degradation of typical
substrates of the ER-associated degradation pathway
- id: PMID:12939278
title: Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar
chains.
findings:
- statement: >-
Fbs2 (Fbxo6b) identified as second F-box protein recognizing N-glycans. Both Fbs1 and
Fbs2 require Man3-9GlcNAc2 for binding. Fbs1 expression restricted to brain and testis
while Fbs2 is ubiquitous.
supporting_text: >-
Although the expression of Fbs1 was restricted to the adult brain and testis,
the Fbs2 transcript was widely expressed
- id: PMID:14990996
title: Structural basis of sugar-recognizing ubiquitin ligase.
findings:
- statement: >-
Crystal structure of Fbxo2 FBA domain with chitobiose at 1.7 angstroms.
Mutagenesis of F177, Y279, W280 abolished glycoprotein binding.
supporting_text: >-
Efficient binding to an N-glycan requires di-N-acetylchitobiose (chitobiose).
Here we report the crystal structures of the sugar-binding domain (SBD) of Fbs1
alone and in complex with chitobiose
- id: PMID:15723043
title: Glycoprotein-specific ubiquitin ligases recognize N-glycans in unfolded substrates.
findings:
- statement: >-
Fbs1/Fbs2 interact preferentially with denatured glycoproteins by sensing exposed
chitobiose. SCF(Fbs1) associates with p97/VCP AAA ATPase.
supporting_text: >-
Both Fbs1 and Fbs2 proteins interacted with denatured glycoproteins, which were
modified with not only high-mannose but also complex-type oligosaccharides, more
efficiently than native proteins. Given that Fbs proteins interact with innermost
chitobiose in N-glycans, we propose that Fbs proteins distinguish native from
unfolded glycoproteins by sensing the exposed chitobiose structure
- id: PMID:15809437
title: Activity-dependent NMDA receptor degradation mediated by retrotranslocation
and ubiquitination.
findings:
- statement: >-
Fbxo2 binds high-mannose glycans of NR1 ectodomain and promotes NR1 ubiquitination.
Dominant-negative Fbxo2 augments NR1 levels and NMDA receptor currents at
glutamatergic synapses in an activity-dependent manner.
supporting_text: >-
the F-box protein, Fbx2, bound to high-mannose glycans of the NR1 ectodomain.
F-box proteins specify ubiquitination by linking protein substrates to the
terminal E3 ligase. Indeed, ubiquitination of NR1 was increased by Fbx2 and
diminished by an Fbx2 dominant-negative mutant
- id: PMID:17215248
title: A neural-specific F-box protein Fbs1 functions as a chaperone suppressing glycoprotein
aggregation.
findings:
- statement: >-
Fbxo2 prevents formation of cytosolic aggregates of retrotranslocated unfolded
glycoproteins. Functions as both ubiquitin ligase component and anti-aggregation
factor. Predominantly detected as heterodimer with Skp1.
supporting_text: >-
In vitro, Fbs1 prevented the aggregation of the glycoprotein through the
N-terminal unique sequence of Fbs1
- id: PMID:17389369
title: Structural basis for the selection of glycosylated substrates by SCF(Fbs1)
ubiquitin ligase.
findings:
- statement: >-
Crystal structures of Skp1-Fbs1 complex and SBD-glycoprotein complex reveal that
the sugar-binding domain primarily recognizes Man3GlcNAc2, explaining broad
glycoprotein substrate specificity.
supporting_text: >-
The structure of the SBD-glycoprotein complex indicates that the SBD primarily
recognizes Man(3)GlcNAc(2), thereby explaining the broad activity of the enzyme
against various glycoproteins
- id: PMID:17494702
title: Selective cochlear degeneration in mice lacking the F-box protein, Fbx2, a
glycoprotein-specific ubiquitin ligase subunit.
findings:
- statement: >-
Fbxo2 knockout mice develop progressive hearing loss due to degeneration of cochlear
epithelial support cells, hair cells, and spiral ganglion neurons. Expression enriched
in brain and cochlea.
supporting_text: >-
Mice with targeted deletion of Fbxo2 develop age-related hearing loss beginning at 2
months. Cellular degeneration begins in the epithelial support cells of the organ of
Corti
- id: PMID:9173930
title: Identification of candidate proteins binding to prion protein.
findings:
- statement: >-
Fbxo2 (then unnamed) identified as candidate prion protein binding partner using
PrP-AP probe to screen mouse brain cDNA library. Four of six isolated clones were
novel and expressed preferentially in brain.
supporting_text: >-
PrP-AP was used to screen a lambdagt11 mouse brain cDNA library, and six clones
were isolated. Four cDNAs are novel while two clones are fragments of Nrf2
(NF-E2 related factor 2) transcription factor and Aplp1 (amyloid precursor-like
protein 1)
core_functions:
- description: >-
Substrate-recognition component of the SCF(Fbxo2) E3 ubiquitin-protein ligase complex
that recognizes N-linked high-mannose oligosaccharides on misfolded glycoproteins
retrotranslocated from the ER to the cytosol, promoting their ubiquitination and
proteasomal degradation via the ERAD pathway.
molecular_function:
id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
directly_involved_in:
- id: GO:0036503
label: ERAD pathway
- id: GO:0006516
label: glycoprotein catabolic process
locations:
- id: GO:0005829
label: cytosol
in_complex:
id: GO:0019005
label: SCF ubiquitin ligase complex
supported_by:
- reference_id: PMID:12140560
supporting_text: >-
N-glycan serves as a signal for degradation by the Skp1-Cullin1-Fbx2-Roc1
(SCF(Fbx2)) ubiquitin ligase complex
- reference_id: PMID:17389369
supporting_text: >-
In SCF ubiquitin ligases, a diverse array of F-box proteins confers substrate
specificity. Fbs1/Fbx2, a member of the F-box protein family, recognizes
high-mannose oligosaccharides
- description: >-
Binds N-linked high-mannose oligosaccharides, specifically recognizing the innermost
chitobiose (Man3GlcNAc2) core of N-glycans. This lectin-like activity is the basis
for substrate recognition in ERAD. Binding is enhanced when glycoproteins are
denatured because denaturation exposes the normally buried chitobiose structure.
molecular_function:
id: GO:0030246
label: carbohydrate binding
supported_by:
- reference_id: PMID:15723043
supporting_text: >-
Fbs proteins interact with innermost chitobiose in N-glycans
- reference_id: PMID:17389369
supporting_text: >-
The structure of the SBD-glycoprotein complex indicates that the SBD primarily
recognizes Man(3)GlcNAc(2)
- description: >-
At glutamatergic synapses in the brain, Fbxo2 mediates activity-dependent degradation
of NMDA receptor NR1 subunits by binding their high-mannose glycans and promoting
ubiquitination, thereby regulating synaptic transmission.
molecular_function:
id: GO:1990756
label: ubiquitin-like ligase-substrate adaptor activity
directly_involved_in:
- id: GO:0099576
label: regulation of protein catabolic process at postsynapse, modulating synaptic
transmission
locations:
- id: GO:0098978
label: glutamatergic synapse
supported_by:
- reference_id: PMID:15809437
supporting_text: >-
the F-box protein, Fbx2, bound to high-mannose glycans of the NR1 ectodomain.
F-box proteins specify ubiquitination by linking protein substrates to the
terminal E3 ligase. Indeed, ubiquitination of NR1 was increased by Fbx2 and
diminished by an Fbx2 dominant-negative mutant
proposed_new_terms:
- proposed_name: misfolded glycoprotein sensor activity
proposed_definition: >-
Recognition of N-glycans on misfolded glycoproteins to target them for
ubiquitin-dependent degradation. Distinct from chaperone activity (no protein
refolding) and from general misfolded protein binding (recognition is glycan-mediated
rather than via exposed hydrophobic patches). Examples include Fbxo2 (Fbs1) and
Fbxo6 (Fbs2) in the ERAD pathway.
justification: >-
No existing GO term precisely captures the mechanism of Fbxo2. "Denatured protein
binding" (GO:0031249, being obsoleted) is inaccurate because Fbxo2 binds glycans
not the protein moiety. "Misfolded protein binding" (GO:0051787) implies direct
recognition of misfolded protein conformation. "Carbohydrate binding" is correct
but does not capture the quality-control context. A term for glycan-based misfolded
glycoprotein recognition would fill this gap. See also the UNFOLDED_PROTEIN_BINDING
project discussion of "misfolded protein sensor activity."
suggested_questions:
- question: >-
Is Fbxo2's anti-aggregation function (suppressing aggregation of retrotranslocated
glycoproteins in the cytosol, PMID:17215248) independent of its ubiquitin ligase
activity, and does it warrant a separate GO annotation?
- question: >-
Should the amyloid-beta binding annotation (GO:0001540, PMID:9173930) be removed
entirely? The original paper identified Fbxo2 as a candidate PrP-binding protein,
not an amyloid-beta binder. Any binding to PrP or APP family members is likely
glycan-mediated.
- question: >-
Would a more specific MF term like "N-glycan binding" or "high-mannose oligosaccharide
binding" be appropriate for Fbxo2, rather than the general "carbohydrate binding"?
suggested_experiments:
- description: >-
Test whether Fbxo2 binds non-glycosylated misfolded proteins to definitively
distinguish glycan-dependent vs protein-conformation-dependent recognition. This
would clarify whether GO:0051787 (misfolded protein binding) is ever appropriate
for Fbxo2.
hypothesis: >-
Fbxo2 does not bind non-glycosylated misfolded proteins because its binding mechanism
is entirely glycan-dependent via the FBA domain.
- description: >-
In Fbxo2 knockout cochlea, identify accumulated glycoprotein substrates by
proteomics to better understand the ERAD substrates relevant to hearing loss
pathogenesis (building on PMID:17494702).
hypothesis: >-
Specific cochlear glycoproteins accumulate in Fbxo2 knockout mice, revealing the
ERAD substrates whose failed degradation causes cochlear degeneration.